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TIIVISTELMÄ 
Ravinnolla on tiedetty olevan vaikutuksia mielialaan, mutta vain vähän johdonmukaisia 
tutkimuksia on julkaistu. Tämä tutkimus mielialahäiriöiden ja ravinnon välisistä yhteyk-
sistä perustuu kahteen aineistoon: syövänehkäisytutkimukseen (SETTI) ja bipolaari-
kaksostutkimukseen. Masennuksen ja ravinnon saannin välisten yhteyksien selvittämiseksi 
tutkittiin 29 133 keski-ikäistä suomalaista miestä,  jotka tupakoivat. Miehet osallistuivat 
väestöpohjaiseen seurantatutkimukseen 5–8 vuoden ajan. Ravinnon saanti on laskettu 
ruokavaliokyselystä ja tiedot mielialasta saatiin kyselystä, jonka tutkittavat täyttivät 3 
kertaa vuodessa. Vakavan masennuksen vuoksi sairaalahoitoon joutuneiden tiedot saatiin 
sairaaloiden hoitoilmoitusrekisteristä ja itsemurhien tiedot väestörekisteristä. Bipolaari-
kaksostutkimuksessa aineisto on kerätty yleisväestöstä. Henkilöt valittiin hoitoilmoitus-
rekisteristä, niiden joukosta joilla vuosien 1969–1991 aikana on diagnosoitu bipolaari-
häiriö. Näistä potilaista on väestörekisteristä etsitty vuosina 1940–1969 syntyneet kaksoset 
ja heille lähetettiin kutsu tutkimukseen (n = 76). 67 tutkittavaa osallistui haastattelututki-
mukseen, jonka yhteydessä he täyttivät kyselyn vuodeaikavaihtelun vaikutuksesta 
mielialaan (SPAQ) ja myöhemmin 39 tutkittavaa täytti lisäksi ruoankäyttökyselyn (FFQ) 
ravinnosta ja Horne-Östbergin (MEQ) kyselylomakkeen vuorokausimieltymyksistä.
Tutkimuksessa ei löytynyt tilastollisesti merkiseviä yhteyksiä ruoasta saatujen ravinto-
aineiden ja mielialan väliltä. Kuitenkin terveiden ja sairaiden ravinnon saannissa oli poik-
keavuuksia. Miehet, jotka olivat olleet sairaalahoidossa vakavan masennuksen vuoksi sai-
vat ravinnostaan enemmän seriiniä ja lysiiniä. Myöskin miehet, jotka ilmoittivat masen-
nuksen ja ahdistuksen tunteista sekä unettomuudesta käyttivät alkoholia enemmän kuin 
terveet henkilöt. Bipolaaripotilaat saivat ravinnostaan B12-vitamiinia enemmän kuin terveet 
henkilöt. Myös bipolaaripotilailla oli terveitä enemmän vuodenaikavaihtelua unen pituu-
dessa ja mielialassa. Tämän tutkimuksen tulosten mukaan ravinnon saannilla ja mielilalla 
ei ole voimakasta yhteyttä. Lisätutkimuksia tarvitaan selvittämään ravinnon ja mielialan 
välisiä yhteyksiä. 
Avainsanat: masennus, bipolaarihäiriö, ravinto, uni, omega-3 rasvahapot, vitamiinit, 
aminohapot 
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SUMMARY 
Diet has an effect on mood, but few studies have examined associations between dietary 
intakes of nutrients and mood disorders. These associations warrant investigation. In this 
work, two samples of study subjects were used. For major depressive disorder we studied 
29,133 men involved for five to eight years in a prospective, population-based trial in 
Finland (the Alpha-tocopherol, Beta-carotene (ATBC) Cancer Prevention Study). Nutrient 
intakes were calculated from a diet history questionnaire. Self-reports of mood symptoms 
were recorded three times a year, data on hospital treatment due to depressive disorders 
were derived from the national Hospital Discharge Register, and suicides were identified 
from death certificates. For bipolar disorder, all Finnish same-sex twins born from 1940 to 
1969 were screened for a diagnosis of bipolar type I disorder (n = 76). Sixty-nine study 
participants filled in the Seasonal Pattern Assessment Questionnaire (SPAQ), and 39 
completed the Food Frequency Questionnaire (FFQ) and Morningness-Eveningness 
Questionnaire (MEQ).  
In present study, it found no significant associations between dietary intakes of nutrients 
and mood disorders in this study. However, there were some variations in intakes of food 
and nutrients between persons with mood disorders or mood symptoms compared with 
healthy individuals. Two amino acids associated with major depressive disorder. Subjects 
with symptoms of depression, anxiety or insomnia consumed more alcohol than healthy 
subjects. The dietary intake of vitamin B12 was greater in bipolar patients than in healthy 
subjects. Moreover, those with bipolar disorder had greater seasonal changes in mood and 
sleep length. These results do not support the view that dietary nutrient intakes have a 
major role in mental health. Further studies are needed to explore associations and 
connections between nutrient intakes and mental health.  
Keywords: major depression, bipolar disorder, diet, sleep, omega-3 fatty acids, amino 
acids, vitamins 
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3 ABSTRACT 
It is suggested that diet has an effect on mood, but only a few studies have explored 
associations between dietary intakes of nutrients and mood disorders. The primary aim of 
this study was to investigate possible associations between dietary intakes of amino acids, 
omega-3 fatty acids and vitamins, and mood symptoms and disorders. Another study aim 
was to assess circadian preference, sleep length and seasonal patterns in mood and 
behaviour among twins with bipolar disorder, and whether seasonal changes influence 
nutrient intake. 
Methods
This work involved two samples of study subjects were used: one for major depressive 
disorder, and one for bipolar type 1 disorder. For major depressive disorder, the study 
population consisted of 29,133 male smokers aged 50 to 69 years who entered the Alpha-
Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study for 5-8 years. This was a 
placebo-controlled trial to test whether supplementation with alpha-tocopherol or beta-
carotene prevents lung cancer. At baseline 27,111 men completed a diet history 
questionnaire from which food and alcohol consumption and nutrient intakes were 
calculated. The questionnaire on background and medical history included three items on 
mental wellbeing, anxiety, depression and insomnia experienced in the past four months. 
Self-reports of mood symptoms were recorded three times a year, data on hospital 
treatment due to depressive disorders were derived from the national Hospital Discharge 
Register, and suicides were identified from death certificates. 
For bipolar disorder the data were taken from a study of all Finnish same-sex twins born 
from 1940 to 1969 who were screened for a diagnosis of bipolar type I disorder (n= 76). 
The diagnosis was assessed using a structured research interview (SCID). Sixty-nine of the 
study participants filled in the Seasonal Pattern Assessment Questionnaire, and 39 of them 
later completed the Food Frequency Questionnaire and Morningness-Eveningness 
Questionnaire. For studying the persistence of habitual sleep and the consumption of 
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alcohol and smoking of tobacco, data from the Finnish Twin Cohort Questionnaire were 
used. Bipolar twins were compared with their healthy co-twins. 
Results
There were no associations found between dietary intakes of amino acids, omega-3 fatty 
acids or vitamins, and mood disorders and symptoms. Only two amino acids, serine and 
lysine, associated with major depression, their intakes being higher higher in subjects with 
depressive disorder than in healthy subjects. Energy intake was higher in men who 
reported anxiety or depressed mood, and those reporting any such symptoms consumed 
more alcohol. Dietary intakes of protein and vitamin B12 were higher in those with bipolar 
disorder than in healthy individuals. Bipolar patients also experienced larger seasonal 
changes in sleep length and mood. 
Conclusions 
There was no significant association between dietary intakes of nutrients and mood 
disorders in this study. However, there was some variation in intakes of food and nutrients 
between persons with mood disorders or mood symptoms compared with healthy 
individuals. These results do not support the view that dietary intakes of nutrients have a 
major role in mental health, although more studies are needed to clarify the associations 
found.
12 
4 INTRODUCTION 
Mood disorders are a significant health problem throughout the world. Major depression is 
estimated to be the fourth most important illness causing functional disability worldwide 
and has been projected to become the second leading cause of disability worldwide by 
2020 (Murray and Lopez, 1996; 1997). It is the fastest growing reason for early retirement 
and in Finland major depression is the most common reason for early disability pensions 
(Salminen et al. 1997; Finnish Centre for Pensions, 2005). Bipolar disorder is another 
serious psychiatric disorder causing great disability. It is the sixth leading cause of 
disability worldwide (Murray and Lopez, 1996). The estimated lifetime prevalence of 
major depression ranges from 10 to 30%. The lifetime prevalence of bipolar I disorder is 
0.24% in Finland (Perälä et al. 2007) and varies from 0.1 to 4.8% in general populations 
worldwide (Rihmer and Angst, 2005).  
Although there have long been suggestions that diet can have an effect on mood, very few 
studies have investigated associations between dietary intakes of various nutrients and 
mood disorders. It has been noted that there are differences in the diet of subjects with 
depressed mood compared to the healthy subjects. Depressed subjects consume more 
carbohydrates than healthy subjects and they have heightened preference for sweet 
carbohydrates (Christensen and Somers, 1996; Christensen, 2001). 
There have also been associations notes between deficiency of specific nutrients and mood 
symptoms. Deficiency of certain vitamins (folate, vitamin B12, and vitamin B1) can cause 
depressive symptoms. It has been reported that depressed patients have low levels of folate 
in their serum and red blood cells (Carney et al. 1990; Fava et al. 1997; Bottiglieri et al. 
2000; Lerner et al. 2006). Tryptophan is a precursor for serotonin that is known to play a 
key role in mood regulation. Tryptophan depletion produces depressive symptoms, 
especially for depressed patients with remission (Neumeister et al. 1998; Spillmann et al. 
2001). Societies with a high consumption of fish appear to have a lower prevalence of 
depression (Hibbeln, 1998) and it has been reported that omega- 3 fatty acids may alleviate 
the symptoms of mood disorders (Stoll et al. 1999; Su et al. 2003). However, there are also 
conflicting findings (Marangell et al. 2003; Silvers et al. 2005). Against the 
aforementioned background, the topic of this thesis appeared to offer a fruitful opportunity 
for a more detailed analysis of the relationships between nutrition and mood disorders. 
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5 REVIEW OF THE LITERATURE 
5.1 Mood disorders 
Mood disorders include depressive and bipolar disorders. This study focuses on major 
depressive disorder (MDD) and bipolar type I disorder. 
5.1.1 Major depressive disorder 
Public health 
Major depression forms a significant health problem in many countries. It is estimated to 
be the fourth most important illness to cause functional disability worldwide and has been 
projected to become the second leading cause of disability worldwide by 2020 (Murray and 
Lopez, 1996; 1997). It is the fastest growing reason for early retirement and in Finland 
MDD is the most common reason for early disability pensions (Salminen et al. 1997; 
Finnish Centre for Pensions, 2005). MDD also causes great individual harm to both 
patients and their relatives. 
Prevalence of depression 
Finland’s the Health 2000 project reports the 12-month prevalence of MDD to be 4.9% 
(Pirkola et al. 2005). MDD is more common among women than men (6.3% vs. 3.4%). In 
the USA, the lifetime prevalence of MDD in the general population is 16.6% and the 12-
month prevalence was 6.7 percent (Kessler et al. 2005a; 2005b). 
Clinical course 
MDD is characterized by severe symptoms of depression. According to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM)-IV, MDD is defined as two or more weeks 
of low mood or diminished interest in usual activites, combined with four or more of the 
following symptoms: sleep alteration (increased or decreased), inappropriate guilt or loss 
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of self-esteem, altered appetite (increased or decreased), diminished energy, diminished 
concentration, psychomotor symptoms, or suicidal ideation (American Psychiatric 
Associations, 1994). There is an increased risk of suicide in patients with MDD (Harris and 
Barraclough, 1997). It has been estimated that lifetime risk of suicide is 6% for affective 
disorders (Inskip et al, 1998). The average age of onset is the mid-twenties and for most 
people episodes of MDD last from six to nine months. MDD may present as single or 
recurrent episodes. The risk of relapse over a five- year period has been estimated to be as 
high as 50-85% (American Psychiatric Association, 2000). An episode is considered to 
have ended when the full criteria for the major depressive episode have no been fulfilled 
for at least four consecutive months (Rush et al. 2006). Depressed patients often have 
somatic symptoms. It is estimated that 69% to 92% of depressed patients have somatic 
symptoms such as headache, chest pain, back pain and constipation (Kroenke and Price, 
1993; Ebert and Martus, 1994; Simon et al. 1999; Corruble and Guelfi, 2000). Morover, 
10% of patients with mood disorders have a seasonal pattern of recurrence (Faedda et al. 
1993). Patients with seasonal affective disorder (SAD) have a seasonal pattern in their 
symptoms. Depressed episodes typically occur in autumn or winter and usually followed 
by recovery the following spring or summer. Fatigue, hypersomnia and increased appetite 
are typical symptoms of SAD. 
Etiology and pathogenesis of depression 
MDD is a multifactorial, heterogenous disorder with a wide range of possible etiologial 
factors. There are genetic, biological and environmental risk factors.  
Heritability and genetic studies 
MDD is a familiar disorder, with most of the familial aggregation resulting from genetic 
factors (Sullivan et al. 2000). A meta-analysis of five methodologically rigorous twin 
studies produced statistically homogeneous results and an aggregate estimate of the 
heritability of MDD of 37% (Sullivan et al. 2000). Kendler et al. (2006) reported that the 
heritability of liability to MDD was significantly higher in women (42%) than men (29%) 
in the Swedish National Twin Study. Recently, molecular genetic studies of MDD and 
gene-environmental interactions have been published. The most promising results have 
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been found for polymorphisms such as the serotonin transporter gene linked promoter 
region (HTTLPR) and brain-derived neurotrophic factor (BDNFV66M) genes in 
depression (Kato, 2007). Recently, it has been found in a prospective birth cohort study 
that a functional polymorphism of the serotonin transporter gene moderates the influence of 
stressful life events on depression (Caspi et al. 2003). 
Neurochemistry
It has been reported that certain monoamines (noradrenaline, serotonin, and dopamine) 
have a role in the pathogenesis of MDD. Most of the anti-depressive medications act 
through an increase in serotonin neurotransmission. It has been reported that depressed 
subjects have reduced serotonin levels in platelets (Le Quan-Bui et al. 1984; Muck-Seler et 
al. 1991). Reduced serotonergic transmission is associated with the pathogenesis of 
depressive illness and suicidal behaviours (Åsberg et al. 1976; Doris et al. 1999; Mann, 
1999). There is increased serotonin transporter activity in the brain of the depressed 
compared to healthy subjects (Malison et al. 1998; Reivich et al. 2004). Several studies 
have demonstrated reduced concentrations of dopamine metabolites both in cerebrospinal 
fluid and in brain in subjects with depression (Dunlop and Nemeroff, 2007). Althought the 
neuroimaging studies support the hypothesis that major depression is associated with a 
state of reduced dopamine transmission (Dunlop and Nemeroff, 2007). Traditional 
antidepressants also increase the concentration of noradrenaline. It has been reported that 
depressed subjects have altered noradrenalin receptor density, but there are also 
contradictory findings (Brunello et al. 2002).  
Environmental risk factors 
Even if heritability of liability to MDD is significant in the etiology of the disorder, 
environmental events account for a substantial portion of the variation in liability. There 
are some environmental risk factors for MDD in the general population. Subjects with 
stressfull and traumatic experiences, such as sexual abuse in early childhood, have 
increased risk of MDD disorder (Kendler et al. 2004). Lindeman et al. (2000) reported that 
factors associated with MDD were urban residency, smoking, alcohol intoxication, and 
chronic medical conditions. Long term unemployment also seems to be an important risk 
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factor to MDD (Hämälainen et al. 2001; 2005). Previously, unemployment was reported to 
associate with mental disorders in the general population (Viinamäki et al. 1995). 
A recent review study reported a median prevalence of current or lifetime alcohol problems 
in depression were 16% (range 5-67%) and 30% (range 10-60%), respectively (Sullivan et 
al. 2005). It has been also reported that daily smoking is associated with MDD (Breslau et 
al. 1998; Ferguson et al. 2003). Psychiatric patients generally have higher rates of tobacco 
smoking than the general population in the USA (Hughes et al. 1986). 
Deficiency of certain nutrients is another cause of depression; examples of such nutrients 
are deficiency of vitamin B6, vitamin B12 and folate (Leklem, 1999; Scott and Weir, 1999; 
Reynolds, 2002).  
5.1.2 Bipolar disorder 
Public Health 
Bipolar disorder is a serious psychiatric disorder which causes great disability. It is the 
sixth leading cause of disability worldwide (Murray and Lopez, 1996) and, like MDD, 
causes great distress and suffering to both patients and their relatives. 
Prevalence and epidemiology of bipolar disorder 
The Health 2000 project reports that the lifetime prevalence of bipolar I disorder in Finland 
is 0.24% (Perälä et al. 2007). The estimated incidence of bipolar I disorder in the Finnish 
population in the period 1970-1991 was 5.8 per 100,000 population (Kieseppä et al. 2000). 
In other countries the lifetime prevalence has varied from 0.1 to 4.8% in general 
populations (Rihmer and Angst, 2005). The lifetime prevalence of bipolar disorder in the 
USA was 2.6% in general population.  
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Clinical course 
Bipolar disorder is characterized by mood swings that alternate between periods of mania 
and periods of depression. According to DSM-IV (American Psychiatric Association, 
1994), mania is defined as a distinct change in mood and functioning lasting at least one 
week, and is characterized by a euphoric or irritable mood accompanied by symptoms such 
as increased energy, decreased need for sleep, rapid thinking and speech, grandiosity, poor 
judgement and impulsivity, and in some cases, psychotic symptoms. For patients with 
bipolar disorder, episodes of mania are often followed by periods of MDD. Patients may 
also have mixed mood states, in which the symptoms of mania and depression occur 
simultaneously, or rapid cycling, where continuous or frequently shifting mood states 
occur.
Seasonal recurrences have been found in 10% of patients with mood disorders (Faedda et 
al. 1993). Shin et al. (2005) reported that subjects with bipolar disorder have as much 
seasonal fluctuation as subjects with seasonal depression. However, there are also 
contradictory findings. Partonen and Lönnqvist (1996) reported that there was no seasonal 
variation among all hospital admissions in subjects with bipolar disorder. 
Bipolar disorder tends to affect men and women equally. The average age of first manic 
episode is the early twenties. Even in patients with continued adherence to medication 
regimens, the risk of relapse over a five-year period has been estimated to be as high as 
73% (Gitlin et al. 1995). The estimated lifetime risk of suicide is 6% for all affective 
disorders in general (Inskip et al. 1998). 
Etiology and pathogenesis of bipolar disorder 
The etiology of bipolar disorder is multifactorial and still poorly understood. Biological 
and especially genetic factors seem to be important for the vulnerability, and 
environmental factors increase the risk. 
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Heritability and genetic studies 
A meta-analysis of 18 family studies arrived at a recurrence risk of bipolar disorder for 
first-degree relatives of bipolar probands of 8.7% and a risk for unipolar depression of 
14.1% (Smoller and Finn, 2003). It has been suggested that familial aggregation is due 
predominantly to genetic factors, with heritability estimates in the range of 60 to 85% 
(Smoller and Finn, 2003). Kieseppä et al (2004) reported a high heritability (93%) of 
bipolar disorder in a nationwide population-based twin study. Numerous studies have 
attempted to localize susceptibility genes for bipolar disorder, but still have not led to a 
consensus about any particular predisposing locus to bipolar disorder. Bipolar disorder is a 
multigenetic disorder determined by several genes. Based on numerous linkage studies 
some chromosomal regions are associated with bipolar disorder (Craddock et al. 2005). 
Also, it has been reported that two genes, D-amino-acid oxidase activator (DAOA) and 
brain derived neurotrophic factor (BDNF), maybe associate with bipolar disorder 
(Craddock et al. 2005). In a recent meta-analysis the polymorphism in serotonin transporter 
gene (5-HTT) showed significant association with bipolar disorder (Lasky-Su et al. 2005). 
Neurochemistry
It has been reported that serotonin has a role in the pathogenesis of bipolar disorder. 
Serotonergic abnormalities have been reported in bipolar disorder, e.g. increased serotonin 
receptors in platelets, a lower maximal velocity of serotonin platelet uptake, and decreased 
brain serotonin neurotransmitter activity (Marazzitti et al. 1991; Prange et al. 1974; Price et 
al. 1990; Pandey et al. 2003). Recently, Oquendo and co-workers (2007) reported that 
patients with bipolar disorder had 16% to 26% lower serotonin transporter bingin potential 
in brain using positron emission tomography compared to healthy controls. 
Sleep and circadian rhythms 
Disturbances of the sleep-wake cycle and circadian rhythms are prevalent in bipolar 
disorder. Changes in the sleep-wake cycle can trigger manic episodes in bipolar disorder 
(Wehr et al. 1987). Experimentally induced sleep deprivation was associated with the onset 
of hypomania or mania in a study of depressed patients (Wu and Bunney, 1990). A recent 
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systematic review study established that sleep disturbance was the most common prodrome 
of mania and the sixth most common prodrome of bipolar disorder (Jackson et al. 2003). 
Harvey et al. (2005) reported that euthymic patients with bipolar disorder also have 
clinically significant sleep disturbance. Moreover, it has been suggested that children of 
bipolar parents have dysregulation of sleep, which may be an early marker of bipolar 
disorder (Jones et al. 2006).  It has been hypothesized that bipolar disorder patients have a 
genetic diathesis that may take the form of circadian rhythm instability. Accordingly, it has 
been reported that sleep deprivation changes the expression of several genes in the cerebral 
cortex of rat’s brains (Terao et al. 2006). 
Twin studies suggest a genetic susceptibility to seasonal changes (Madden et al. 1996; Jang 
et al.1997). It has been hypothesized that mutation in circadian rhythm-related genes can 
cause bipolar disorder, which has strong heritability, but more studies are needed 
(Benedetti et al. 2003; Mansour et al. 2006; Nievergelt et al. 2006). The protein products of 
circadian genes are necessary for the generation and regulation of circadian rhythms (Ko 
and Takahashi, 2006). There is also some evidence that bipolar disorder is associated with 
some circadian rhythm-related genes, with the strongest evidence for the aryl hydrocarbon 
receptor nuclear translocator-like (ARNTL) gene, but more large studies are needed to 
confirm these findings (Benedetti et al. 2003; Mansour et al. 2006; Nievergelt et al. 2006). 
Environmental risk factors 
There are some environmental risk factors which affect bipolar disorder, but the findings 
are still unclear. Stressful life-events later in life may predispose to mania or depression in 
bipolar patients, but their association with the onset of the first episode remains 
controversial (Ambelans, 1987; Ellicot et al. 1990; Scalre and Creed, 1990). An association 
between childhood physical abuse and mania has also been reported (Levitan et al. 1998). 
The lifetime prevalence of alcohol abuse or dependence in patients with bipolar disorder 
has been reported to be 46.2% and 39.2%, respectively (Regier et al. 1990). In addition, 
patients with alcohol dependence tend to have a heightened risk for a lifetime diagnosis of 
co-morbid mania (Helzer and Pryzbeck, 1988). Smoking incidence is high, over 50%, in 
patients with bipolar disorder (Gonzale-Pinto et al. 1998). However, excessive smoking is 
20 
associated with psychotic disorders in general rather than bipolar disorder specifically 
(Corvin et al. 2001). 
There is no evidence that deficiency of specific nutrients can cause bipolar disorder, but 
omega-3 fatty reportedly alleviate the symptoms (Stoll et al. 1999). 
5.2 Mood and food 
Food habits have changed in Finland over the past decades and nowadays resemble those 
of a typical European diet in many ways. Earlier the Finnish diet was largely based on 
grains, milk products, and potatoes. The consumption of grain and starch products has 
since declined, while animal products have increased. Vegetables and fruit consumption 
has also increased steadily (Pietinen et al. 2001). The intake of vitamins and minerals is 
generally adequate (Männistö et al. 2003). 
There was a shortage of studies on relationships between dietary intakes and mood prior to 
the start of the studies presented herein. However, recent years have seen a growing 
interest in exploring these associations and the findings of several studies are presented 
here. Mostly of the studies have attempted to clarify the association between fish 
consumption and depression.  
It has been reported that people with a high consumption of fish appear to have a lower 
prevalence of depression (Hibbeln 1998; Tanskanen et al. 2001a; 2001b, Silvers and Scott 
2002; Timonen et al. 2004). Hibbeln (1998) found that greater seafood consumption was 
related to lower life-time prevalence rates of MDD across nine countries. In two Finnish 
studies a significant reverse association between consumption of fish and depression was 
observed only for females (Tanskanen et al. 2001b; Timonen et al. 2004). It has been also 
reported that increased fish intake in people without depressive symptoms had no 
substantial effect on mood (Woo et al. 2002; Ness et al. 2003).  Noaghiul and Hibbeln 
(2003) reported that greater rates of seafood consumption were associated with lower 
prevalence rates of bipolar disorder in cross-national comparisons across 12 countries. The 
results of the fish studies are seen in Table 1. 
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Hintikka et al. (2005) recently reported that daily tea drinking was associated with a low 
level of depressive symptoms in the Finnish general population. None of those whose daily 
tea intake was five cups or more had depression. Individuals drinking regular coffee with 
caffeine were reported to have decreased total sleep time and sleep quality, and increased 
sleep latency (Shilo et al. 2002). Also, caffeine administration can increase anxiety and 
alertness (Brice and Smith, 2002).  
Table 1.  The Associations between the intake of fish/seafood and mood disorders
Study subjects N Intake of omega 3-fatty 
acids/fish 
Findings Authors 
25-64 year-old  
Finnish adults 
1 772 High consumption / low 
consumption of fish* 
Fish?  mood?
Association 
founded only in 
women. 
Tanskanen et al. 
2001 
25-64 year-old 
Finnish adults 
3 204 High consumption / low 
consumption of fish* 
Fish ? mood? Tanskanen , 2001 
70 year-old and 
over Chinese 
elderly 
2 032 Infrequent, occasional and 
daily consumption 
Fish ? mood? Woo et al. 2002 
Over 15 years old 
New Zealander 
adults 
4 644 Non-fish consumers/ Fish 
consumers 
Fish ? mood? Silvers and Scott, 
2002 
37-70 year-old  
UK men 
377 Fish advice: EPA 8.8 mg/d 
No fish adivice: EPA 8.7 mg/d 
Fish ? mood? Ness et al. 2003 
31 year-old 
Finnish adults 
(birth cohort)  
5 689 Regular fish eaters/ 
Rare fish eaters** 
Fish? mood?
Association 
founded only in 
women. 
Timonen et al. 
2004 
Cross-national 
comparison 
  Fish ?
depression?
Hibbeln, 1998 
Cross-national 
comparison 
  Fish ? bipolar 
disorder?
Noahghiul and 
Hibbeln, 2003 
* Fish were consumed twice a week or more often vs less than twice a month 
** eat fish weekly or more often vs eat fish monthly or more seldom 
? = low consumption, worsened of mood, ? = no effects on mood , ? = high consumption, improved of 
mood  
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5.3  Mood and nutrients 
5.3.1 Macronutrients 
The macronutrients sources of energy are carbohydrates, fats and proteins. Carbohydrates 
are compounds made up of sugars. They are classified by their number of sugar units: 
monosaccharides (such as glucose and fructose), disaccharides (such as lactose and 
sucrose) and bigger molecules, oligo- and polysaccharides. Carbohydrates are the most 
common source of energy, but they are not essential nutrients. 
Fats consist of a glycerol molecule with three fatty acids attached. They are a concentrated 
source of energy, 38 kJ/g (9 kcal/g). Fats are essential nutrients because they include 
essential fatty acids. Fat also is needed to carry and store the essential fat-soluble vitamins, 
like vitamin D.  
Proteins are made up of 20 amino acids, each with different metabolic fates in the body. 
The amino acids that the body cannot manufacture must be supplied in the diet and are 
known as essential amino acids. Sources and recommended intakes of macronutrients are 
seen in Table 2. In Finland the recommended total energy intake for adult malesis 10.4-12 
MJ /day, depending on physical activity (National Nutrition Council, 2005). Carbohydrates 
should supply 50 to 60% of the total energy intake, protein should provide 10 to 20%, and 
fat approximately 30 to 35% (National Nutrition Council, 2005). There few studies of 
associations between macronutrients and mood are presented here. 
Carbohydrates 
Subjects with MDD tend to consume more carbohydrates in their diets than non-depressed 
individuals (Christensen and Somers, 1996), and they show heightened preference for 
sweet carbohydrate or fat- rich foods during depressive episodes (Christensen, 2001). High 
carbohydrate intakes increase brain uptake of the amino acids tryptophan, which in turn 
stimulates the synthesis of serotonin (Rogers, 2001.) This seems, for example, to rapidly 
lead to drowsiness in healthy subjects but to alertness in patients with SAD (Rosenthal et 
al. 1989). A detailed study of the lifestyle of 89 bipolar patients and 445 age- and sex- 
matched controls showed that total daily sucrose intake, %age of energy from 
carbohydrate, and consumption of sweetened drinks were higher in bipolar patients 
(Elmslie et al. 2001). Westover and Marangell (2002) reported a highly significant 
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correlation between sugar consumption and annual rates of depression in a cross-national 
study involving six countries. 
Fats and proteins 
In general, a low-fat diet may have negative effects on mood (Wells et al. 1998), and 
altered dietary fat intake can lead to acute behavioural effects such as drowsiness, 
independent of energy consumption, in healthy subjects (Lloyd et al. 1994). The intake of 
branched-chain amino acids may acutely alleviate manic symptoms in patients with 
adequate drug treatment (Scarnà et al. 2003), and a high intake of proteins also seems to 
increase alertness (Rogers, 2001). 
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Table 2. Food sources of nutrients and recommended intakes.
Sources Recommendations 
Carbohydrates bread and cereals, fruits and berries a* 50-60% of the total energy intake c
Fats fat spreads and oils, meat dishes, meat 
products, milk products a*
approximately 30% of the total energy 
intake c
Proteins meat dishes and products, milk products, 
eggs a*
10-20% of the total energy intake c
Omega-3 fatty 
acids
 1% of the total energy intake c
ALA vegetable oils; 
canola-, soybean-, flaxseed oils, leafy 
green vegetables, nuts, flaxseeds a*
Long-chain omega-
3 fatty acids 
fatty fish; 
salmon, tuna, sardine, herring and mackerel 
a*
Amino Acids meat, cheese, fish and offal a*
Tryptophan reindeer meat, liver, cheese, tuna, nuts, 
soybean, sunflower seed, poppy seeds  b**
4-6 mg/kg/day d
Serine salmon, cheese, eggs, pork, cattle, 
soybeans, nuts, sunflower seed, poppy 
seeds b**
no recommendations 
Lysine cheese, cattle, pork, chicken, sardine, tuna, 
pearch, salmon, cod, carp, lens, soybeans, 
sunflower seeds b**
12-30 mg/kg/day d
Vitamins 
Folate whole grain products, fresh vegetables, 
fruits, meat and eggs a*
300 ?g/day for men and older women 
400 ?g/day for young women c
Vitamin B12,
Cobalamin 
animal products such as meat, fish and 
dairy products a*
2.0 ?g/day c
Vitamin B1 , 
Thiamine 
whole grain products, meat products and 
eggs a*
1.0-1.5 mg/day c
Vitamin B2,
Riboflavin 
dairy products,  meat and egg products a* 1.2 -1.7 mg/day c
Vitamin B6,
Pyridoxine 
meat and egg products, whole grain 
products and fruits and berries a*
1.2-1.6 mg/day c
Vitamin D fish products, milk and margarine a* 7.5 -10 ?g /day c
a (Männistö et al. 2003), b(Souci et al. 1994; Salo-Väänänen, 1996), c (National Nutrition Council, 2005),   
d (Matthews, 1999), * Sources in the Finnish diet, **High content / 100 g of food 
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5.3.2 Amino acids 
The 20 or so amino acids that make up the body’s proteins each have different metabolic 
fates. Amino acids are joined together in long strings by peptide bonds to form proteins of 
differing shapes and sizes. There are eight (nine in infants) essential amino acids for the 
human body:  isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, 
valine and histine. In this present study, tryptophan, lysine and serine were the main focus 
of investigated.  
Tryptophan 
Tryptophan is essential amino acid. It is a precursor for serotonin synthesis. Free 
tryptophan is transported into the brain across the blood-brain barrier by an active protein 
shuttle for which five other large neutral amino acids (valine, leucine, isoleleucine, 
phenyalanine and tyrosine) also compete. In the brain serotonin is synthesized from 
tryptophan. It is first converted into 5-hydroxytryptophan by the enzyme tryptophan 
hydroxylase; 5-hydroxytryptophan is then decarboxylated by the enzyme aromatic acid 
decarboxylase to serotonin. Serotonin is stored in synaptic vesicles where it stays until 
released by a neuronal impulse.  Serotonin is stored in synaptic vesicles where it stays until 
released by a neuronal impulse. Serotonin is destroyed by the enzyme monoamine oxidase 
and converted into an inactivate metabolite, 5-hydroxyindoleaceticacid (Cooper et al. 
1996). Serotonin can also be converted to melatonin in the pineal gland at night. Melatonin 
influences the circadian rhythms. 
Dietary protein and carbohydrate content can specifically influence brain tryptophan and 
serotonin levels by effects on plasma amino acids patterns. Carbohydrate in the diet 
increases secretion of insulin, which raises the plasma concentration of tryptophan and 
decreases the concentrations of other large neutral amino acids. This leads to increased 
tryptophan and thus raises serotonin concentrations in the brain (Fernström and Wurtman, 
1971a; 1971b). Sources and recommended intakes of tryptophan are seen in Table 2.  
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Tryptophan and mood 
Tryptophan is a precursor for serotonin that is known to play a key role in many brain 
functions, such as mood regulation. A number of studies has shown that acute tryptophan 
depletion produces depressive symptoms and results in worsening of mood (Neumeister et 
al. 1998; Spillmann et al. 2001). The results of the most important studies of tryptophan 
depletion in depressed and healthy subjects are seen in Table 3. 
There have been a few studies of tryptophan depletion in patients with bipolar disorder. 
Cappiello et al. (1997) reported increased manic symptoms after tryptophan depletion in 
recently recovered patients. However, in three other studies there were no effects of 
tryptophan depletion in patients treated with lithium (Benkelfat et al. 1995; Cassidy et al. 
1998; Hughes et al. 2000). The results of the most important studies of tryptophan 
depletion in subjects with bipolar disorder are seen in Table 4. 
A number of negative studies have been published recently, suggesting that the effects of 
tryptophan depletion on mood are less consistent in psychiatric patients and healthy 
volunteers (Bell et al. 2001; Van der Does, 2001). The rationale for augmentation has now 
been challenged (Nelson, 2000). Bell et al. (2001) reported in their review article that in 
patients with depression tryptophan depletion tends to result in no worsening of depression 
in untreated subjects but a relapse in those who have responded to antidepressants. In 
addition, Van der Does (2001) found that tryptophan depletion has a mood lowering effect 
only in subgroups of recovered depressed patients, patients with SAD and vulnerable 
healthy subjects. 
There are several reports that plasma tryptophan is significantly lower in patients with 
MDD than in normal controls (Coppen et al. 1973; Cowen et al. 1989).  Recently, Hoekstra 
et al. (2006) reported that bipolar disorder patients had a decreased tryptophan plasma 
levels compared to normal controls. Because tryptophan is a precursor for serotonin, 
tryptophan supplementation has been applied to the treatment of patients with SAD (Lam 
et al. 1997). Lam (1997) has been reported that tryptophan may be an effective 
augmentation strategy for those patients with SAD who show limited or poor response to 
bright ligh therapy.  
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Table 3. Effects of tryptophan depletion in depressed and healthy subjects. 
Study subjects N Findings Authors 
Depressed patients 
(untreated) 
43 Mood? Delgado et al. 1994 
Depressed patients 
(untreated), 
22 Mood? Price et al. 1997 
Depressed patients 
(untreated)  
38 Mood? Price et al. 1998 
Depressed patients 
(remitted),  
21 11/21 relapsed Delgado et al. 1990 
Depressed patients 
(remitted) 
21 7/21 relapsed Bremner et al. 1997 
Depressed patients 
(remitted) 
14 Mood? Leyton et al. 1997 
Depressed patients 
(remitted) 
20 5/12 relapsed with TRP depletion 
0/8 relapsed with no TRP depletion 
Åberg-Wistedt et al. 1998 
Depressed patients 
(remitted) 
24 Mood?
Mood? controls 
Moreno et al. 1999 
Depressed patients 
(remitted) 
22 Mood? Neumeister  et al. 1998 
Depressed patients 
(remitted) 
30 1/15 relapsed with fluoxamine 
8/15 relapsed with desipramine 
Delgado et al. 1999 
Depressed patients 
(remitted) 
10 5/7 relapsed 
1/3 relapsed with placebo   
Spillmann et al. 2001 
Depressed patients 
(remitted)  
41 women, 
18 men 
women mood?
men mood ?
Moreno et al. 2006 
SAD* patients, 
remission 
10 8/10 relapsed Lam et al.  1996 
Healthy subjects 
women 
12 Mood? Oldman et al. 1994 
Healthy subjects  12 Mood? Smith et al. 1997a,b 
Healthy subjects men 10 Mood? Bhatti et al. 1998 
SAD* = Seasonal Affective Disorder, ? = Worsened of mood, ? = No effects on mood,  
? = Improved of mood 
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Serine
Serine it is not an essential amino acids in the human diet. It is produced from 
hydroxypyryvate derived either from glucose or from glycerol. Serine is then used as a 
precursor for glycine through a process that transfers a methylene group to tetrahydrofolate 
(Matthews, 1999). It is precursor for glysine. Sources of serine are seen in Table 2.  
Serine and mood  
Serine acts as a partial agonist at the glycine modulation site of the glutamate receptor in 
the brain and therefore tends to affect brain functions (Watson et al. 1990). Previously, 
high serine plasma concentrations have been suggested to be a potential marker for 
psychotic disorder in general, and for depressive disorder with psychotic symptoms in 
particular (Waziri et al. 1984; Baruah et al. 1991; Mauri et al. 1998), but there are also 
reports of low serine plasma levels in psychotic depressive disorder (Fekkes et al. 1994; 
Maes et al. 1998). Sumiyoshi et al. (2004) recently reported that patients with 
schizophrenia and also those with MDD had increased plasma serine levels compared to 
normal controls. 
Table 4.  Effects of tryptophan depletion in bipolar disorder. 
 Study subjects N Findings Authors 
BD patients in 
remission, men 
10 Mood? Benkelfat et al. 1995 
BD patients, recently 
recovered  
7 Manic symptoms? Cappielo et al. 1997 
BD patients   4 Mood? Cassidy et al. 1998 
BD patients, in 
remission  
19 Mood? Hughes et al. 2000 
First-degree relatives 
of BD patients and 
controls  
30 Relatives+ controls mood? Sobczak et al. 2002 
BD = Bipolar disorder, ? = Worsened of mood, ? = No effects on mood, ? = Symptoms increased 
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Lysine 
Lysine, an essential amino acids for humans, acts as a precursor for the carnitine, which is 
involved in lipid metabolism. Acetylincarnitine is synthesized from carnitine too, and also 
plays a part in lipid metabolism (Pettegrew et al. 2000). Sources and recommended intakes 
of lysine are seen in Table 2. 
 Lysine and mood  
Currently, there are no data regarding the impact of lysine on brain functions or mental 
disorder. In one study lycine fortification of wheat reduced anxiety and stress among an 
economically disadvantaged population in Syria (Smriga et al. 2004).  
5.3.3 Omega-3 fatty acids 
Omega-3 fatty acids are polyunsaturated fatty acids. The omega number indicates the 
number of carbon atoms from the methyl end of the acyl chain to the first double bond. 
The first double bond in an omega-3 fatty acid is three carbons from the methyl end of the 
molecule. Alpha linolenic acid (ALA, 18:3n-3) is an essential fatty acid for humans (Jones 
and Kubow, 1999). ALA can be converted to the longer-chain omega-3 fatty acid, 
eicosapentaenoic acid (EPA, 20:5n-3). EPA can elongated to docosapentaenoic acid 
(22:5:n-3), and then further extended, desaturated, and beta-oxidized to produce 
decosahexaenoic acid (DHA, 22:6n-3) (Jones and Kubow, 1999).  
While ALA is the precursor for longer omega-3 fatty acids, EPA acts as the precursor for 
certain eicosanoids, such as prostaglandins, thromboxane, and leukotriens. Eicosanoids 
play a large role in modulating cardiovascular, pulmonary, immune, reproductive, and 
various secretory functions (Jones and Kubow, 1999). EPA also affects lipoprotein 
metabolism and decreases the production of other compounds, including cytokines, 
interleukin 1b, and tumornecrosis factor ?. The pro-inflammatory cellular activities exerted 
by these compounds include stimulating the production of collagenase and increasing the 
expression of adhesion molecules necessary for leukocyte extravasation (James et al. 
2000). DHA (22:6n-3), one of the main structural lipids in the mammalian brain, plays 
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crucial roles in the development and function of brain neurons. It is also concentrated in 
the retina and testes (Jones and Kubow, 1999).
Sources and recommended intakes of omega-3 fatty acids are seen in Table 2. The intake 
of the combined essential fatty acid (omega-3 plus omega-6) should form at least 3% of 
total energy, including approximately 1% from omega-3 fatty acids (Table 2). If the daily 
energy intake is 8368 kJ (2000 kcal), this means 2-3 g of omega-3 fatty acids per day 
(National Nutrition Council, 2005).  
Population based studies 
Societies with a high consumption of fish appear to have a lower prevalence of depression 
Hibbeln 1998; Tanskanen et al. 2001a; 2001b, Silvers and Scott 2002; Timonen et al. 
2004). However, the dietary intake of omega-3 fatty acids did not associate with depression 
in a study of a community sample of Australian women (Jacka et al. 2004). The dietary 
intake of total omega fatty acids and ALA associated inversely with depression, but the 
intakes of EPA and DHA and also of fish consumption, did not associate with depression 
in Japanese lung cancer patients (Suzuki et al. 2004). Noaghiul and Hibbeln (2003) 
founded a robust correlational relationship between greater seafood consumption and lower 
prevalence rates of bipolar disorder in a comparison across 12 countries. Recently, 
Appleton et al. (2007) founded that higher omega-3 fatty acids intakes from fish associated 
with lower levels of depressed mood, but the association disappeared after adjustment for 
age and social deprivation. 
Concentration studies 
There is evidence that people with MDD have significantly lower omega-3 levels in red 
cell membranes (Edwards et al. 1998; Peet et al. 1998), in serum cholesteryl esters (Maes 
et al. 1999), and in plasma phospholipids (Tiemeier et al. 2003; Frasure-Smith et al. 2004) 
compared to controls. It has also been reported that depressed subjects have lower omega-3 
fatty acid levels in adipose tissue compared to healthy controls (Mamalakis et al. 2004). 
Low EPA levels in red cells have been found in patients with suicide attempts (Huan et al. 
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2004). Green et al. (2006) also reported decreased levels of omega-3 in red blood cells 
membrane in patients with social anxiety disorder. 
De Vriese et al. (2004) reported seasonal variation in polyunsaturated fatty acid levels in 
humans. EPA and DHA levels are lower in winter. They suggested that this seasonality 
may be related to the incidence of violent suicide. They also suggested that annual 
variations of essential fatty acids are related to the expression of the serotonin markers, 
such as the Bmax [3H]-paroxetine binding to platelets.
Supplemental studies 
Results of some supplement-based trials are seen in Table 5. A placebo-controlled, double 
blind trial with 28 depressed patients found that omega-3 fatty supplements (9.6 g/day for 8 
weeks) alleviated the effects of depressive symptoms (Su et al. 2003). However, a double 
blind, placebo-controlled trial of DHA (2g/day for 6 weeks) in a sample of 36 clinically 
depressed patients demonstrated no significant improvements in the treatment group 
compared to controls (Marangell et al. 2003). Silvers et al. (2005) reported that fish oil 
(3g/d omega-3 for 12 weeks) treatment did not improve mood when compared to the 
placebo oil in depressed patients.  Two clinical studies have used doses of 1 to 2 g per day 
of EPA ethyl ester to successfully treat patients with depression. Nemets et al (2002) 
reported that in a double blind, placebo-controlled trial with 20 MDD patients who 
responded only partially to standard antidepressant treatment, EPA ethyl ester supplements 
(2g/d for 4 weeks) alleviated depressed symptoms. Also, a double blind, placebo-
controlled trial with 52 depressed patients with antidepressant treatment showed that an 
EPA ethyl ester supplements (1g/day/12 weeks) was effective in treating depression in 
patients who remained depressed despite adequate drug treatment (Peet and Horrobin, 
2002). However in this study, only a dosage of 1 g/day showed efficacy compared to 2-4 
g/day dosages. A randomized, placebo-controlled, adjunctive trial of EPA (6 g/day for 4 
months) in the treatment of bipolar depression and rapid cycling bipolar disorder did not 
find overall evidence of efficacy for adjunctive treatment (Keck et al. 2006). In a recent 
double blind, placebo-controlled trial on 231 young adult prisoners, antisocial behaviour as 
measured by the number of their disciplinary offences before and during the 
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supplementation, was reduced by the supplementation of vitamins, minerals and essential 
fatty acids (Gesch et al. 2002).  
A placebo-controlled trial with 30 patients found that omega-3 fatty acid pharmacological 
dose supplements (9.6g/day for 4 months) alleviated symptoms of depression in patients 
with bipolar disorder (Stoll et al. 1999). They also had longer periods of remission than the 
placebo group. Treatment of bipolar disorder with adjunctive EPA (1 to 2 g/day for 12 
weeks) resulted in improved clinical outcomes compared with placebo in terms of scores 
on the Hamilton Rating Scale for Depression and the Young Mania Rating Scale (Frangou 
et al. 2006). 
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Table 5. Associations between dietary intake or supplemental use of omega 3 –fatty acids and mood.
Study Subjects N The intake of omega-3 
fatty acids (g/day) 
Findings Authors 
23-97 year-old 
Australian women 
755 Total omega-3 fatty acids: 
0.11 g/day 
Mood ? Jacka at al. 2004 
Japanese lung 
cancer patients 
771 Total omega intake was  
1.52 g/d for subjects 
without depression and 
1.43g/d for depressed 
subjects 
Fish: Mood?
Total omega -3 
fatty acids: mood?
Suzuki et al. 2004 
General 
population (UK) 
2982 Total omega intake was 1.6 
g/day, intake of omega-3 
fatty acids from fish was 
0.6 mg/day 
Omega-3 fatty 
acids from fish 
associated with 
lower levels of 
depressed mood, 
but the association 
disappeared after 
adjusting for age 
and social 
deprivation. 
Appleton et al. 
2007 
18-70 year-old  
depressed patients 
(UK) 
70 E- EPA 1, 2 or 4 g/day, or 
placebo 
1 g/d  mood?
2.4 g/d mood?
Peet et al. 2002 
28-73 year-old 
depressed patients 
(Israel)  
20  E-EPA 
 2g/day, or placebo 
Mood? Nemets et al. 
2002 
18-60 year-old 
depressed patients 
(Taiwan) 
22 EPA + DHA 9.6 g/d, or 
placebo 
Mood? Su et al. 2003 
18-65 year-old 
depressed patients 
(USA) 
35 DHA 2 g/d, or placebo Mood? Marangell et al. 
2003 
18-65 year-old 
depressed patients 
(New Zealand) 
59 EPA + DHA 3g/d, or 
placebo 
Mood ? Silvers et al. 2005 
Young adult 
prisoners (UK) 
231 EPA+ DHA 1.24 g/d, 
+omega-6 fatty acids 1.42 
g/d, or placebo 
Reduced 
antisocial 
behaviour 
Gesch et al. 2002 
18-65 year-old  
patients with 
bipolar disorder 
(USA)  
30 9.6 g/d  omega-3 fatty 
acids, or placebo 
Remission ? Stoll et al. 1999 
18-70 year-old 
patients with 
bipolar disorder 
(UK)  
75 1 g/d  or 2 g/d E-EPA, or 
placebo 
Mood?
HRDS?*
CGI?** 
Frangou et al. 
2006 
20-73 year-old 
patients with 
bipolar disorder 
(USA)  
116 E-EPA 6g/day, or placebo  Mood? Keck et al. 2006 
* HRDS = Hamilton Rating Scale for Depression, ** CGI = Clinical Global Impression Scale 
? = Worsening of mood, ? = No effects on mood, ? = Improvement of mood 
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5.3.4 Vitamins 
Folate
Folate belongs to the group of water-soluble B vitamins. There are over 100 different 
forms of folate in diet. Folate acid is the synthetic form of folate. They are essential for 
humans like all vitamins. Folate acts as coenzyme in numerous metabolic pathways in the 
body. It is required for the synthesis of thymidylate and thus for deoxyribonucleic acid 
(DNA). Folate is also necessary in protein synthesis and is especially important during 
periods of rapid cell division and growth, such as infancy and pregnancy (Herbert, 1999). 
One possible manifestation of folate deficiency is megaloblastic anaemia is a, which results 
from decreased synthesis of DNA and ribonucleic acid. Folate deficiency is characterized 
by weakness, dyspnea, diarrhea, weight loss, and neurological symptoms. Folate deficiency 
is associated with a high frequency of irritability, forgetfulness, and hostile and paranoid 
behaviour (Herbert, 1999). Sources and recommended intakes of folate are seen in Table 2. 
In addition, deficiencies of folic acid as well as pyridoxine (B6) and vitamin B12 , can lead 
to high homocysteine levels as a consequence of their involvement in homocysteine 
metabolism (Miller et al. 1994). Homocysteine is a sulphur-containing amino acid formed 
from the essential amino acid methionine. A high blood level of homocysteine is 
associated with hightened risk of ischaemic heart disease and stroke risk (Homocysteine 
Studies Collaboration, 2002). 
Folate and mood 
Folate deficiency has been known to be linked to depressive disorder, and it has particular 
effects on mood, and on cognitive as well as social function (Bottiglieri, 1996; Alpert and 
Fava, 1997; Reynolds 2002). Depressed patients have been shown to have low levels of 
folate in their serum and red blood cells (Carney et al. 1990; Fava et al. 1997; Bottiglieri et 
al. 2000; Lerner et al. 2006). Findings of folate and vitamin B12 studies are seen in Table 6. 
It has been also reported that patients with low folate status have been weaker treatment 
response to antidepressants (Abou-Saleh and Coppen, 1989; Carney et al. 1990; Fava et 
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al.1997), and folate replacement therapy in patients with MDD appears to produce 
substantial affective improvements (Godfrey et al. 1990; Mischoulon 1996; Coppen and 
Bailey, 2000). It has been reported that depressed individuals in the general US population 
had lower serum and red blood cell folate concentrations (Morris et al. 2003). Low serum 
folate also associated with an increased severity of depressive symptoms in a 
epidemiological sample of middle-age individuals in Australia (Sachdev et al. 2005) 
However, Penninx et al. (2000) did not find an association between blood folate and 
depression among disabled older women, although Ramos et al (2004) reported that low 
folate status was associated with depressive symptoms in elderly Latino women, but not 
elderly Latino men. Other findings suggest that folate deficiency is not independently 
related to the depressive disorders (Tiemeier et al. 2002), and low plasma folate levels are 
not significantly related to depression in a general population in Norway (Bjelland et al. 
2003). Recently, it have been reported that low levels of dietary folic acid are associated 
with elevated depressive symptoms and MDD in middle-aged men (Tolmunen et al. 2003; 
2004a).  The data regarding an association between folate and mania are scarce, but red 
blood cell folate levels in patients with mania have been reported (Hasanah et al. 1997). 
Recently, several studies have shown that total plasma homocysteine is a sensitive marker 
of functional deficiency of either folic acid or vitamin B12. The synthesis of methionine 
from homocysteine requires a supply of methyl groups from methyl folate, and also 
vitamin B12 as a cofactor. Thus functional deficiency of either vitamin results in raised 
plasma levels of homocysteine (Lindenbaum et al. 1988; Stabler et al. 1988), and a high-
folate diet decreases plasma homocysteine concentration (de Bree et al. 2001a; Silaste et al. 
2003). It has been reported that depressed patients had raised plasma homocysteine 
(Lindenbaum et al. 1988; Bottiglieri et al. 2000; Bjelland et al. 2003), but not all studies 
have found this association (Fava et al. 1997; Pennincx et al. 2000; Tiemeier et al. 2002). 
Recently, Tolmunen et al. (2004b) reported that high serum concentrations of 
homocysteine associated with depression in middle-aged men. Smoking is also known to 
be associated with an increased plasma homocysteine level and reduced of levels of folate, 
vitamin B12 and vitamin B6 (de Bree et al. 2001b; O’Callaghan et al. 2002).  
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Table 6. Association between serum folate, vitamins B, and mood disorders. 
Study subjects N Blood fragment Findings Authors 
Elderly Dutch 
people 
694 Plasma concentration Folate? Mood?
Vitamin B12? Mood?
Tiemeier et al. 
2002 
English inpatients 
(MDD), the mean 
age 34 years 
84 Plasma concentration Folate? Mood?
Homocysteine ??
Folate? Mood ?
Vitamin B12? Mood?
Bottiglieri et al. 
2000 
46- 49 and 70-74 
year-old Norwegian 
adults 
5 948 Plasma concentration Folate? Mood?
(Middle- aged women 
Folate? Mood ?)
Vitamin B12? Mood?
Bjelland et al. 2003 
Depressed patients 
(the mean age 59.5) 
and normal controls 
(the mean age 44.7) 
155 Red blood cell 
concentrations 
Folate? Mood? Abou-Saleh and 
Coppen, 1989 
English depressed 
patients 
285 Red blood cell 
concentrations 
Folate? Mood?
Vitamin B12? Mood?
Carney et al. 1990 
American patients 
(MDD), the mean 
age 39.9 years  
213 Serum concentrations Folate? Mood ?
Vitamin B12? Mood?
 Fava et al. 1997 
15-39 year-old US 
population 
2 948 Serum concentrations Folate? Mood?
Vitamin B12? Mood?
Morris et al. 2003 
Elderly Latinos,   
> 60 year-old 
1 463 Plasma concentrations Folate? Mood? women 
Folate? Mood? men 
Vitamin B12? Mood?
Ramos et al. 2004 
60-64 year-old 
Australian adults 
412 Serum concentrations Folate? Mood?
Vitamin B12? Mood?
Sachdev et al. 2005 
Israeli psychiatric 
patients (MDD), the 
mean age 39.4 
years 
224 Serum concentration Folate? Mood ?
Vitamin B12? Mood?
Lerner et al. 2006 
Manic  hospitalised 
patients and normal 
controls from 
Malaysia  
78 Serum concentrations 
and red-cell 
concentrations 
Folate? (red-cell) Mood? Hasanah et al. 1997 
Elderly  Dutch 
women,  > 65 
years-old 
700 Serum concentrations Vitamin B12? Mood?
Folate? Mood?
Penninx et al. 2000 
21-69 year-old  
Finnish outpatients 
(MDD) 
115 Red blood cell 
concentrations 
Vitamin B12? ? good 
treatment outcome 
Folate ?Mood?
Hintikka et al. 
2003 
19-92 year-old 
Danish adults 
140 Plasma concentrations Vitamin B6?Mood?
Folate? Mood?
Vitamin B12? Mood?
Hvas et al. 2004a 
? = Worsened mood, low levels of vitamin, ? = No effects on mood, ? = improved mood, high levels of 
vitamin 
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Vitamin B12 (Cobalamin) 
Vitamin B12, also known as cobalamin, belongs to the group of water-soluble B vitamins, 
all of which are essential for humans. Vitamin B12 is a coenzyme in two metabolic 
reactions. The methylcobalamin form is needed as one of the coenzymes involved in the 
synthesis of methionine from homocysteine. It is necessary in small amounts for the 
formation of proteins and red blood cells, and for the function of the central nervous 
system and maintenance of the inner lining of the intestinal tract. One clinical 
manifestation of vitamin B12 deficiency is megaloblastic anaemia. It can also cause 
paresthesia, constipation, peripheral neuropathy, depressive symptoms and dementia (Scott 
and Weir, 1999). Sources and recommended intakes of vitamin B12 are seen in Table 2. 
Vitamin B12 and mood 
Vitamin B12 deficiency has been linked to various neuropsychiatric disorders including 
affective illness (Hector and Burton 1988; Lindenbaum et al. 1988; Healton et al. 1991). It 
has been reported that depressed subjects have low serum vitamin B12 levels (Pennincx et 
al. 2000, Tiemeier et al. 2002), but there are also contradictory findings (Fava et al. 1997; 
de Jong et al. 2001). Recent population-based studies have not found an association 
between vitamin B12 levels and symptoms of depression (Bjelland et al. 2003; Morris et al. 
2003; Sachdev et al. 2005)  It has been reported that high levels of vitamin B12 are 
associated with good treatment outcome in patients with MDD (Hintikka et al. 2003). In a 
study of Hvas et al. (2004a) supplemental vitamin B12 treatment did not improve cognitive 
function or symptoms of depression within the three-month study period. The results 
vitamin B12 studies are seen in Table 6.  
Folate and vitamin B12 deficiency may be caused by a number of factors including dietary 
deficiency, malabsorption, and increased requirement for these vitamins during stress 
(Abou-Saleh and Coppen, 1986). Both folate and vitamin B12 are essential in several 
metabolic pathways in the central nervous system, and their metabolism is intimately 
connected (Abou-Saleh and Coppen 1986; Chanarin et al. 1989). A deficiency of either 
vitamin causes impaired methylation in the central nervous system and may result in 
neurological and psychiatric disease that becomes irreversible if not treated properly 
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(Hector and Burton, 1988). Also, vitamin B12 has been reported to modulate human 
melatonin secretion (Yamazaki et al. 1991). Intravenous administration of vitamin B12
increased rectal temperature in the later hours the daytime (Uchiyama et al. 1995). In the 
study of Hashimoto et al. (1996) light exposure phase-advanced the melatonin rhythm in 
the vitamin B12-receiving group but not in the placebo group. Thus, vitamin B12 seems to 
enhance the light-induced phase-shift in the human circadian rhythm. As circadian rhythms 
are disturbed in depression and in mania, similar mechanisms could also take place in the 
association between vitamin B12 and depression. However, these connections have been 
studied only in healthy volunteers.
Vitamin B1 (Thiamine) 
Vitamin B1, also known as thiamine, is another water-soluble B vitamin essential for 
humans. Vitamin B1 serves biochemically as the coenzyme of a-keto acid decarboxylation 
and transketolation. It is needed in the body cells to convert carbohydrates, proteins and 
fats into energy. Vitamin B1 also has a role in neurophysiology. It is concentrated in nerve 
cell membranes and also in muscle cells. It facilitates impulse conduction in peripheral 
nerves. Vitamin B1 deficiency, which is common in alcoholism, can produce confusion and 
psychotic symptoms, in addition to neurological signs (Petrie and Ban, 1985). Deficiency 
of vitamin B1 can cause two clinical manifestations: beriberi and Wernicke-Korsakoff 
syndrome. Wernicke-Korsakoff syndrome is cause by chronic alcohol abuse. Wernicke-
Korsakoff syndrome causes a derangement of mental function and it can also lead to 
psychosis. Vitamin B1 by injection and perorally are used to prevent Wernicke-Korsakoff 
syndrome. Other symptoms of deficiency of vitamin B1 are cardiac failure, muscle 
weakness, peripheral and central neuropathy, and gastrointestinal malfunctions 
(Tanphaichitr, 1999). Vitamin B1 supplementation had reported to improve general well-
being in elderly women (Smidt et al. 1991). Sources and recommended intakes of vitamin 
B1 are seen in Table 2. 
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Vitamin B2 (Riboflavin) 
Vitamin B2, is also known as riboflavin. It participates in oxidation-reduction reactions in 
numerous metabolic pathways and in energy production via the respiratory chain. It is vital 
for body growth and red blood cell production and is also involved in the release of energy 
from carbohydrates. Deficiency of vitamin B2 is characterized by sore throat, hyperaemia, 
and oedema of pharyngeal and oral mucous membranes, cheilosis, and normochromic, 
normocytic anaemia (McCormic, 1999). Sources and recommended intakes of vitamin B2
are seen in Table 2. Vitamin B2 also plays a role in thyroxine metabolism, and deficiency 
may contribute to the pathophysiology of mental disorders via this route (Bell et al. 1992).  
Vitamin B6 (Pyridoxine) 
Vitamin B6 exists in three major chemical forms: pyridoxine, pyridoxal, and pyridoxamine 
all of which are essential water-soluble vitamins. Vitamin B6 functions as a cofactor to 
numerous enzymes in metabolic pathways. It is a coenzyme for reactions that to synthesize 
several neurotransmitters, including serotonin, dopamine, and nerepinephrine. Vitamin B6
is involved in gluconeogenesis via its role in transaminations and in the action of glycogen 
phosphorylase. Also, it has a significant impact on immune function and red cell 
metabolism. Deficiency of vitamin B6 can cause depression, confusion, irritability, 
stomatitis, cheilosis and glossitis (Leklem, 1999). Sources and recommended intakes of 
vitamin B6 are seen in Table 2. 
Vitamin B6 is involved in the same metabolic pathways in the central nervous system as
vitamin B12 and folate. Hvas et al. (2004b) found a low level of plasma vitamin B6
associated with symptoms of depression. It has also been reported in two studies that 
vitamin B6 supplementation has positive effects on memory performance, but not on mood 
(Deijen et al. 1992; Bryan et al. 2002). 
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Vitamin D 
Vitamin D is a fat-soluble vitamin. It is found in food, and also the human body makes it 
when exposed to ultraviolet B rays from the sun. Vitamin D exists in several forms, each 
with a different level of activity. Calciferol is the most active form of vitamin D, other 
versions being relatively inactive in the body. The liver and kidney help convert vitamin D 
to its active hormone state (van den Berg, 1997). Once vitamin D is produced in the skin or 
consumed in food, it requires hydroxylation in both liver and kidney to 1.25 
dihydroxyvitamin D, the physiologically active form. Active vitamin D functions as a 
hormone because it sends a message to the intestines to increase the absorption of calcium 
and phosphorus (van den Berg, 1997). 
The principal physiologic function of vitamin D is to maintain serum calcium and 
phosphorus concentrations in a range that supports cellular processes, neuromuscular 
function, and bone ossification. Experimentally, vitamin D suppresses the proliferation of 
normal and malignant cells and induces differentiation and apoptosis (Ylikomi et al. 2002). 
Vitamin D deficiency can cause rickets in children and osteomalacia in adults. The 
symptoms are muscular weakness in addition to weak bones. 
Sources and recommended intakes of vitamin D are seen in Table 2. Ultraviolet B rays 
from the sun trigger vitamin D synthesis in the skin (Holick et al. 1994; 2002). Season, 
latitude, time of day, cloud cover, smog, and sunscreen all affect ultraviolet B ray exposure 
and vitamin D synthesis (Wharton et al. 2003). At northern latitudes there are marked 
seasonal fluctuations in serum 25-hydroxyvitamin D levels the serum concentrations being 
high during summer and low during winter due to the marked difference in sunlight 
exposure (Tjellesen and Christiansen 1983; Lamberg-Allardt 1984; Hine and Roberts 
1994; Davies et al. 1999). In Finland, a northern European country, there is no short-
wavelength ultraviolet light reaching the ground in wintertime. Since the synthesis of 
vitamin D in the skin is therefore reduced, dietary vitamin D is important for maintaining a 
normal vitamin D status at the northernmost latitudes throughout the year (Lamberg-
Allardt et al. 1983; Webb et al. 1988; Holick 1995). 
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Vitamin D and mood 
Vitamin D supplementation during winter also seems to improve mood in healthy 
volunteers (Lansdowne and Provost, 1998). One possible mechanism of action is that 
serum 1,25-dihydroxyvitamin D levels affect the levels of serotonin in the hypothalamus 
(Privette et al. 1991) and thereby enhance the synthesis and transmission of serotonin, 
leading to improvement in mood. However, Dumville and co-workers (2006) recently 
reported that daily supplementation of vitamin D did not improve the mental well-being of 
elderly women during winter months. 
5.4 Relevance of this study 
In summary, there are no consistent findings of associations between nutrition and mood, 
although some specific nutrients have been suggested to relate to mood. Tryptophan has 
slight effects on mood, mostly in depressed patients. Tryptophan depletion studies have 
noted effects on mood, mainly in depressed subjects or those with vulnerability to 
depression. There are no relevant data about effects of other amino acids on mood. There is 
conflicting evidence on whether omega-3 fatty acids can be used in the treatment of mood 
disorders. Also, only a few studies have found an association between dietary intake of 
fish, a major source of long chain omega-3 fatty acids, and mood. Folate deficiency causes 
depressed symptoms and there are differences in folate status in depressed patients. 
Deficiency of folate mainly appears to affect mood in older people or subjects with 
depression. The evidence on the effects of vitamin B12 on mood is conflicting. The role of 
other vitamins (B1, B2, B6, D) in mood regulation is still unclear. There are no previous 
studies of dietary intake in subjects with bipolar disorder. 
Because of the shortage of previous reports and lack of evidence, the topic of this thesis 
provided a useful opportunity to make a more detailed analysis of the relationships 
between nutrition and mood disorders. The focus of the study is on the specific nutrients 
which are suggested to relate to mood and mood disorders. 
42 
6 AIMS OF THE STUDY 
The primary aim was to analyse whether there were significant associations of dietary 
intakes of nutrients with mood disorders (I, II, III, IV). 
Another aim was to study whether seasonal changes in mood and circadian preferencefor 
activities had significant relations to diet (IV, V). 
A third aim was to elucidate whether insomnia, sleep debt or seasonal changes in sleep 
duration, i.e. length of sleep, were linked to dietary intakes in mood disorders (III, IV, V). 
To answers these questions, the specific aims were formulated as follows. 
I. To study associations between dietary intake of amino acids and low mood, 
depression, and suicide.  
The main question was: Is the intake of tryptophan related to depression? 
(Study I)
II. To study associations between dietary intake of omega-3 fatty acids and low mood, 
depression, and suicide. Consumption of fish rich in long-chain omega-3 fatty 
acids, specifically, was assessed.  
The main question was: Is the intake of omega-3 fatty acids related to depression?
(Study II) 
III. To study whether food consumption and intake of nutrients in subjects with 
depressed mood, anxiety and insomnia differed from those in subjects without any 
such symptoms.  
The main question was: How does mood affect eating habits? (Study III) 
IV. To study the intake of nutrients and consumption of food items among twins with 
bipolar disorder, and also to study the consumption of alcohol and cigarette 
smoking. In addition, to elucidate the influence of seasonal changes in mood and 
behaviour on nutrient intake. 
The main question was: How does bipolar disorder affect eating habits?
(Study IV) 
V. To study seasonal variations in hospital admission and self-reported well-being in 
twins with bipolar disorder. Another aim was to study the effect of natural light 
exposure on mood. Another aim was to assess circadian preference, sleep length 
and seasonal patterns in mood and behaviour among twins with bipolar disorder. 
The main question was: How does bipolar disorder affect seasonal changes in 
mood and behaviour, and especially sleep? (Study V)
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7 SUBJECTS AND METHODS 
In the present work two samples of study subjects were used: one for studies of major 
depressive disorder, another for studies of bipolar type 1 disorder. 
7.1 The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study 
(ATBC Cancer Prevention study) (I, II, III) 
The Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study was a double-
blind, placebo-controlled, randomized primary prevention trial testing the hypothesis that 
daily supplementation with ?-tocopherol or ?-carotene reduces the incidence of lung and 
other cancers (ATBC Cancer Prevention Study Group, 1994). 
7.1.1 Study subjects 
The study participants were recruited between 1985 and 1988 from the total male 
population 50-69 years of age residing in southwestern Finland (n=290,406). These men 
were sent a questionnaire on current smoking status and willingness to participate in the 
trial. Smokers of at least five cigarettes per day and who were willing to participate were 
then invited to visit their local study center for further evaluation of their eligibility. A 
previous cancer diagnosis, current severe angina with exertion, chronic renal insufficiency, 
cirrhosis of the liver, alcohol dependence, or a disorder limiting participation in the long-
term trial, such as mental disorder or physical disability, were reasons for exclusion. A 
total of 29,133 men were randomly assigned to receive supplements of either ?-tocopherol, 
?-carotene, both, or placebo, in a 2x2 factorial design. The ethics review boards of the 
participating institutions approved the study, and all subjects provided written informed 
consent prior to randomization. 
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7.1.2 Follow-up 
Active intervention continued for all participants through April 1993 and ranged from five 
to eight years (median 6.1 years). 
7.1.3 Assessment of mood and behaviour 
Data on hospital admissions for MDD and mania were derived from the National Hospital 
Discharge Register, which covers in-patient admissions to all medical and psychiatric 
hospital beds in Finland. The accuracy of the register compared with medical records is 
excellent, with data being identical in about 95% of the primary diagnoses (Keskimäki and 
Aro, 1991). The diagnoses were coded according to the International Classification of 
Diseases (ICD-8) (World Health Organization, 1968) up to the end of 1986, and according 
to the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) (American 
Psychiatric Association, 1987) thereafter. Later diagnoses, after 1995, were coded 
according to the ICD-10. A total of 280 men were hospitalized at least once for MDD 
(included MDD and depressive disorder NOS) by the end of 1994. 
In a new analysis (unpublished data) a total of 247 men were hospitalized at least once for 
MDD (including only MDD, not depressive disorder NOS) by the end of May 2001. A 
total of 48 men were hospitalized due to manic episodes at least once by the end of May 
2001.  
Data on deaths were derived from the Central Population Register, and the cause of death 
was reviewed from the death certificates. A total of 102 men committed suicide during the 
follow-up. The follow-up of survival extended to the end of 1994. 
At baseline, subjects completed a questionnaire on their medical history, including three 
questions on mental wellbeing. These items concerned anxiety, depressed mood and 
insomnia experienced in the past three months (Have you felt feelings of depression in the 
last three months? Have you felt feelings of anxiety in the last three months? Have you had 
insomnia in the last three months?). 
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The trial involved three follow-up visits annually. At each follow-up visit the participants 
were asked whether they had felt anxiety, depression, or insomnia since the preceding visit. 
To identify subjects who suffered chronically from these symptoms, those reported 
throughout the first follow-up year were taken into account, i.e. at baseline and the three 
follow-up visits (4 months, 8 months and 12 months). Men reporting anxiety, depression, 
insomnia, or all these symptoms at all four visits were considered as cases and those 
without symptoms as controls in these analyses (Study III). 
7.1.4 Assessment of food consumption 
Diet and alcohol consumption were assessed from a self-administered dietary history 
questionnaire (Pietinen et al. 1988), which asked the frequency of consumption and the 
usual portion size of 276 food items during the past year. In the questionnaire there was a 
photographic picture booklet with 122 food items and mixed dishes to help in estimating 
portion sizes (Haapa et al. 1985). Complete dietary data were available for 27,111 
participants. Dietary nutrient data were analyzed by linking the questionnaire data to the 
food composition database of the National Public Health Institute, Finland. 
7.1.5 Assessment of other characteristics 
At baseline, subjects completed a questionnaire about their general background and 
medical and smoking histories. Height and weight were also measured, and a blood sample 
was drawn for determining serum total and high-density lipoprotein (HDL) cholesterol 
concentrations. Concentrations of cholesterols were assessed using an enzymatic method. 
46 
7.2 Twin Study (IV, V) 
7.2.1 Study subjects 
Study participants were searched from the National Hospital Discharge Register of Finland 
to identify all patients with at least one of the ICD-8 codes 296.10 or 296.30 in 1969–86 
(World Health Organization, 1967), or DSM-III-R codes 296.4, 296.5 or 296.6 in 1987–91 
(American Psychiatric Association, 1987). Dates for each admission were recorded. The 
National Population Register was thereafter used to locate twins born between 1940 and 
1969. Also, the Finnish Twin Cohorts were checked to identify any additional twins 
(Kaprio et al. 1990). One twin pair with no history of mental illness was included to 
increase the number of healthy controls. All the 76 participants identified were sent an 
invitation to participate with their co-twin in the study (See in Figure 1). 
The twin study was approved by the Ethics Committee of the National Public Health 
Institute, and by the Ministry of Social Affairs and Health. Written informed consent was 
obtained from all subjects after they received a complete description of the study. 
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Figure 1. Study sample of the  Twin Study 
National Hospital Discharge Register
National Population Register 
Finnish Twin Cohort
?
?
?
?
Abbreviations: BP= bipolar disorder 
7.2.2 Diagnostic assessment 
All the probands and co-twins (n=67) were interviewed  by one of the investigator (T.K) to 
confirm diagnosis of the probands and to assess any mental disorders of the co-twins by 
using the Structured Clinical Interview for DSM-IV Disorders (SCID) (Spitzer et al. 1997). 
Interviews were made blind to zygosity. The zygosity determination was based on genetic 
marker analysis, and on questionnaires on resemblance during childhood (Sarna et al. 
1987). 
N= 76  BP patients 
and healthy controls
Interview
Seasonal Pattern Assessment Questionnaire
N= 67 (total) N= 39 (BP patients), 20 (healthy 
controls) and 8 (subjects with other mental 
disorder) 
Years 1998-1999
N=61, 6 refuced 
further contacts
Food Frequency Questionnaire
Morningness-Eveningness Questionnaire 
N= 39 (total) N=20 (BP patients),  
12 (healthy controls),  
7 (subjects with other mental disorder) 
Year 2002
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7.2.3 Assessment of seasonal changes in mood and behaviour 
First, 67 participants filled in the Seasonal Pattern Assessment Questionnaire (SPAQ; 
Rosenthal et al. 1984) and they were then invited to research interviews that took place 
from November 1998 to December 1999. Thirty-nine of them had bipolar disorder, with 
mean age 44.3 years (range 29-57), and 20 were assessed as healthy (no mental disorder), 
with mean age 44.7 years (range 33-57). In addition, eight had a mental disorder other than 
bipolar disorder, and were excluded from further analysis. There was a greater proportion 
of men among the bipolar twins than healthy twins, but no difference in the affection status 
by zygosity. The number of discordant pairs was 15. 
SPAQ was used for the assessment of seasonal variation in length of sleep, social activity, 
mood, weight, appetite, and energy level (Rosenthal et al. 1984). The sum of these six 
scales yields the Global Seasonality Score (GSS), which can range from 0 (no change) to 
24 (extremely marked change). This questionnaire also investigated the changes in 
wellbeing caused by local weather conditions. The sum of these ten scales (cold weather, 
hot weather, humid weather, sunny days, dry days, long days, grey cloudy days, high 
pollen count, foggy smoggy days, and short days) yields a global score, designated here as 
the Global Weather Score (GWS), which can range from -30 to + 30. Negative scores 
indicate negative effects and positive scores indicate positive effects of changes in weather 
conditions on feelings of wellbeing. In addition, two new variables were made from the 
SPAQ, and coded and analysed separately: light exposure (the sum of sunny days, and long 
days) and grey, cloudy days (the sum of grey cloudy days, foggy smoggy days, and short 
days). 
7.2.4 Assessment of food consumption 
Six twins refused any further contact early on, and 61 twins were finally sent the Food 
Frequency Questionnaire (FFQ) and the Morningness-Eveningness Questionnaire (MEQ) 
(Horne and Östberg, 1975) in January 2002 (See Figure 1). The response rate was 67% (41 
out of 61). An additional two participants were excluded at baseline because of 
incompletely filled FFQs. Of the 39 respondents, 20 had bipolar disorder, with mean age 
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46.6 years (range 32-60), and 12 were assessed as healthy (no mental disorder), with mean 
age 46 (range 33-58). In addition, seven had mental disorder other than bipolar disorder, 
and were excluded from further analysis. Diagnoses of other mental disorders were 
schizoaffective disorder, recurrent MDD, schizophrenia, and alcohol abuse. 
The FFQ is a validated questionnaire (Paalanen et al. 2006) that was used in the Health 
2000 Survey. It is a modified and updated version of two Finnish questionnaires used in 
earlier studies, the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (Pietinen et 
al. 1988) and the Kuopio Breast Cancer Study (Männistö et al. 1996). The FFQ is designed 
to cover the whole diet over the preceding 12 months, and the main purpose is to rank 
individuals according to their average food consumption and nutrient intake. The 128 food 
items are presented under 12 subgroups, e.g. dairy products, vegetables and fruits and 
berries. After each subgroup there are empty lines for subjects to add foods not listed in the 
questionnaire. The portion sizes are fixed and, if possible, specified using natural units 
(e.g. glass, slice).  Recipes for each food item in the FFQ are composed of one to seven 
food codes in the Finnish food composition database Fineli® (release 2) that is published 
in part on the Internet (National Public Health Institute, 2002).  The nine frequency 
categories range from never or seldom to six or more times a day. The consumption of 
berries is recorded separately in winter and summer. The food consumption and nutrient 
intakes are calculated by multiplying the frequency of food consumption by fixed portion 
sizes to obtain the weight of each listed food item consumed as an average per day. 
7.2.5 Assessment of circadian type 
The Morningness-Eveningness Score (MEQ) is a self-report questionnaire that has been 
used for the assessment of preferred timing of behaviour (Horne and Östberg, 1975). The 
questionnaire includes 19 items, and the sum yields the Morningness-Eveningness Score 
(MES), which can range from 16 to 86. The highest scores indicate definite morningness, 
and the lowest ones definite eveningness. Morning types go to bed earlier and also rise 
earlier in the morning than evening types. 
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7.2.6  Assessment of other characteristics 
The Finnish Twin Cohort Questionnaire (FTCQ) was used to study the sleep length and the 
subjective feeling of sleep debt (Study V) (Kaprio and Koskenvuo, 2002). Data were 
available from 1975, 1981 and 1990. The overall response rate was 89% in the 1975 
survey, 84% in 1981, and 77% in 1990. The FTCQ also included two questions about sleep 
length ("How many hours do you usually sleep at night?", and "How many hours do you 
estimate you need to sleep, to feel refreshed next day?"). A new variable, sleep debt, was 
calculated from two questions by subtraction. 
To study alcohol consumption and tobacco smoking (Study IV), data available from FTCQ 
in 1981 and 1990 were used. There were additional questions concerning the consumption 
of coffee and tea separately (cups per day). The questionnaire requested information on the 
frequency and quantity of alcohol used during an average week (or month), and the number 
of years smoked. For each type of beverage (spirits, wines, beer), consumption was 
converted into grams of absolute alcohol and summed to yield an estimate of total 
consumption in grams per day. 
7.3 Statistical analyses 
7.3.1 The ATBC Cancer Prevention Study 
Cox’s proportional hazards regression models were used to analyse of the relationships 
between the baseline dietary intakes of nutrients, and the first occurrence of self-reported 
depressed mood, first hospital admission period for either major depressive or bipolar 
disorder, and suicide (I, II). The intakes of nutrients were included in the models as quartile 
or tertile categories. Intakes of amino acids and omega-3 fatty acids were included in the 
models as tertile categories (II). The analyses (I, II, III) also compared the highest decile 
with the middle category. To limit the effect of confounding factors, the analyses were 
repeated after excluding subjects who had given a self-report of depressed mood already at 
study entry (I, II). 
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The dietary factors were adjusted for energy intake in the models (Willet, 1990). Possible 
risk factors for mood disorders entered into the models as covariates included age, body-
mass index, energy intake, serum total cholesterol, serum HDL cholesterol, consumption of 
alcohol, education, marriage, self-reported depression, self-reported anxiety and smoking 
(I, II). The estimated relative risks and their 95% confidence intervals (CI) were calculated. 
Calculations were also done to test the association between consumption of fish and self-
reported depressed mood. 
7.3.2 Twin studies 
To take into account the correlated nature of twin data, adjusted Pearson F-statistics and 
Wald tests for clustered data were used to compare bipolar with healthy twins (Stata 
Corporation, 2001) (V). This method accomodates the pairs in which both twins had 
bipolar disorder. Survey estimation prevalences were applied to assess the domain and sum 
variables of the data derived from the questionnaires (Colombo et al. 2000) (V). Wilcoxon 
signed ranks tests were computed for the analysis of differences in these scores within the 
discordant twin pairs, i.e. where one twin had bipolar disorder and the other did not. Intra-
pair correlations were calculated for the GSS and GWS, and partial correlation coefficients 
to estimate the association between the MES and the GSS (V). Also, partial correlation 
were calculated to estimate the association between food items, nutrients and seasonal 
changes and circadian phenotype after controlling for sex, age, zygosity, and affection 
status (IV). Chi-square and Fisher's exact tests were used for the analysis of differences in 
categorical variables. Means and standard deviations of food consumption and nutrient 
intake were calculated. Nutrient intakes were adjusted for energy intake according to the 
residual method in the models (Willet, 1990.) Mann-Whitney, logistic regression, and 
linear regression tests were used for the analysis of continuous variables (IV, V). In the 
present studies the significance level of the test was p < 0.05. 
52 
8 RESULTS 
8.1 Amino acids 
The average intake of amino acids at baseline did not differ in subjects with self-reported 
depression, anxiety, insomnia, and hospital admission due to MDD, and suicide (Table 2, 
in I and Table 2, in III). 
Significance associations 
Two amino acids were associated with subsequent hospital admissions due to MDD, the 
relative risk (95% CI) being 1.40 (1.02-1.93) for lysine and 1.38 (1.00-1.90) for serine in 
the highest tertile, as compared with the lowest tertile (Study I). However, these 
associations disappeared after excluding those with self-reported depressed mood at study 
entry. Then, the relative risk (95% CI) was 0.87 (0.24-1.50) for lysine and 1.10 (0.42-1.76) 
for serine in the highest tertile, as compared with the lowest tertile. 
No significance associations 
There were no significant associations between the intake of any amino acids and the risk 
of self-reported depressed mood , the risk of hospital admission due to MDD or the risk of 
death from suicide during the follow-up (Table 2, in I). Tryptohan did not associate with 
depression. The highest decile and the lowest decile were also compared with the middle 
tertile of dietary intake of amino acids for each study end-point, but there were no 
significant differences (Table 3, in I). There was no significant association between the 
intake of amino acids and self-reported depressed mood, anxiety or insomnia (Table 2, in 
III). (Study III) 
The main results of studies between amino acids and association of self-reported depressed 
mood, anxiety, insomnia, hospital admission due to MDD, or insomnia are seen in Table 6. 
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8.2 Omega-3 fatty acids and fish  
Significance associations 
A small, marginally elevated risk of self-reported depression was suggested in the highest 
tertile of fish consumption compare to the lowest tertile the relative risk (95% CI) being 
1.06 (1.00-1.12). A small, marginally elevated risk of self-reported depression was 
suggested in the highest tertile of fish consumption compared as to the lowest tertile.The 
trend test showed the statistical significance of high fish consumption for self-reported 
depressed mood (Z=2.09, df=1, p=0.04) (Study II).   
No significance associations 
There were no significant associations of fish consumption or omega-3 fatty acids intake 
with self-reported depression, hospital admission due to depression or suicide (Table 1, in 
II) (Study II). Also, there was no significant association of fish consumption or intake of 
omega-3 fatty acids with bipolar disorder (Study IV). In addition, women with bipolar 
disorder ingested 26% less omega-3 fatty acids than healthy women, but the difference was 
not statistically significant. There were no significant associations of fish consumption or 
intake of omega-3 fatty acids with self-reported depression, anxiety or insomnia (Table 2, 
in III). 
There were variations in the intake of omega-3 and omega-6 fatty acids between study 
groups, although the differences were not statistically significant. In subjects with 
depressed mood, the mean intake of omega-6 fatty acids was 7% greater than in symptom-
free subjects. In individuals with anxiety, the mean intake of omega-6 fatty acids was 7% 
greater and that of omega-3 fatty acids from vegetables 5% greater than in subjects with no 
symptoms.
When the symptoms reported during the first trial follow-up year were taken into the 
analysis, some variation has founded. Both in subjects with depressed mood and with 
anxiety, the mean intake of total omega-3 fatty acids was 9% greater and that of omega-3 
fatty acids from vegetables 6% greater than in respective symptom-free subjects, whereas 
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the mean intake of omega-6 fatty acids was 6% greater in subjects with depressed mood 
and 9% greater in subjects with anxiety. 
The main results of studies between omega-3 fatty acids and fish, and the risk of self-
reported depressed mood, anxiety, insomnia, hospital admission due to MDD, or insomnia 
are seen in Table 6. 
8.3 Vitamins 
Significance associations 
In linear regression analysis, after adjustment for sex and age, the intake of vitamin B12
was significantly associated with bipolar disorder (t=2.1, p < 0.05) (Study IV). The mean 
intake of vitamin B12 was 48% (7.9 μg) greater in the bipolar twins than in healthy 
individuals, but the difference was not statistically significant. The difference was stronger 
in women; the intake of vitamin B12 was 44% greater in women with bipolar disorder than  
in healthy women. 
Table 6. Results of the present study by end-points: self-reported depression, self-
reported anxiety, self-reported insomnia, hospital admission due to MDD, suicide, and 
bipolar disorder.
Amino Acids Significant differences No significant differences 
   Tryptophan  No association with any of study end- 
points.
   Serine Associated with hospital admission due 
to MDD. 
Associations disappeared after excluding 
those with the self-report of depressed 
mood at study entry
   Lysine Associated with hospital admission due 
to MDD. 
Associations disappeared after excluding 
those with the self-report of depressed 
mood at study entry 
Omega- 3 fatty 
acids 
No association between any of study 
end-points. 
Fish Highest tertile of fish consumption 
associated with the risk of self-reported 
depression. Trend test showed 
significance of fish consumption for self-
reported depressed mood.   
No association between other end-points. 
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No significance associations 
There were no significant associations between the intakes of any other vitamins and self-
reported depression, anxiety, or insomnia (Table 2, in III). (Study III) 
Additional data on vitamins 
Baseline characteristics of the study subjects with a hospital admission due to MDD and 
due to bipolar disorder are given in Table 7, and the intakes of dietary vitamins B and D in 
Table 8. The intakes on average were similar in all groups. There were no significant 
associations of intakes of vitamins or homocysteine with any of the study end-points 
(Table 9). Dietary intake of vitamin D was associated with baseline serum total and HDL 
cholesterol levels (r=0.14, p=0.02, and r=0.12, p=0.05, respectively). 
Table 7. Results of the present study by end-points: self-reported depression, self-
reported anxiety, self-reported insomnia, hospital admission due to MDD, and mania, 
suicide, and bipolar disorder. 
Vitamins Significant differences No significant differences 
B12, Cobalamin  
Associated with vitamin B12 in 
the linear regression analyses. 
No association between other end- 
points. 
Folate  
 No association between any of study 
end-points. 
B1, Thiamine 
 No association between any of study 
end-points. 
B2, Riboflavin  
No association between any of study 
end-points. 
B6, Pyridoxine  
 No association between any of study 
end-points. 
Vitamin D  
 No association between any of study 
end-points. 
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Table.8 Baseline characteristics of subjects with hospital admission due to major depressive  
disorder and  to manic episodes.*  
 Depression Mania Whole cohort 
 n=244 n=48 n= 28 844 
  Mean s.d Mean s.d Mean s.d 
Age (years) 56.9 5.02 56.1 4.13 57.7 5.08 
Energy (kcal/day) 2845 837 2823 895 2814 786 
Smoking (cig/day) 21.5 9.28 24.9 10.1 20.4 8.82 
Alcohol (g/day) 16.8 19.8 18.5 30.7 18.0 21.6 
Body mass index (kg/m2) 26.3 4.06 27.3 4.48 26.3 3.81 
Total serum cholesterol (mmol/l) 6.17 1.16 6.15 1.19 6.24 1.17 
HDL serum cholesterol (mmol/l) 1.21 0.33 1.13 0.30 1.23 0.34 
*There were no significant differences between groups and the whole cohort. 
Table 9. The intake of vitamins by hospital admission due to major depressive disorder and due to manic 
episode. * 
 Depression Mania Whole cohort 
 n=244 n=48 n= 28 844 
  Mean s.d Mean s.d Mean s.d 
B12, Cobalamin (?g/day) 11.5 5.14 12.2 5.88 11.1 4.8 
Folate (?g/day) 344 109 356 122 337 104 
B1, Thiamine (mg/day) 2.12 0.62 2.05 0.66 2.07 0.59 
B2, Riboflavin (mg/day) 3.03 1.02 3.08 1.10 2.93 0.98 
B6, Pyridoxine (mg/day) 2.59 0.73 2.56 0.82 2.51 0.71 
Vitamin D (?g/day) 5.39 3.39 5.64 3.57 5.49 3.10 
*There were no significant differences between groups and the whole cohort. 
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Table 10. Relative risk (RR)a and 95% confidence intervals (CI) of hospital admission  
due to major depressive disorder and to manic episode by  baseline intake of  vitamins. 
Intake of vitamins (in quartile)b Depression Mania 
B12, Cobalamin (?g/day) < 7.7 1.00     1.00  
 7.7-10.3 1.05 0.86-1.29 1.01 0.59-1.73 
 10.3-13.5 1.06 0.94-1.18 0.88 0.62-1.26 
 > 13.5 1.04 0.96-1.13 1.01 0.79-1.28 
      
B6, Pyridoxine (mg/day) < 2.0 1.00  1.00  
 2.0-2.4 1.06 0.86-1.31 0.70 0.40-1.22 
 2.4-2.9 1.06 0.94-1.20 0.73 0.47-1.14 
 > 2.9 1.09 0.99-1.20 1.09 0.82-1.45 
      
B1, Thiamine (mg/day) < 1.7 1.00  1.00  
 1.7-2.0 0.94 0.75-1.17 0.55 0.27-1.08 
 2.0-2.4 1.11 0.97-1.27 0.89 0.57-1.37 
 > 2.4 1.12 0.99-1.26 1.13 0.80-1.58 
      
B2, Riboflavin (mg/day) < 2.2 1.00  1.00  
 2.2-2.8 0.87 0.70-1.08 1.08 0.62-1.88 
 2.8-3.5 1.10 0.97-1.24 0.95 0.66-1.37 
 > 3.5 1.09 0.99-1.20 1.09 0.82-1.45 
      
Folate (?g/day) < 265 1.00  1.00  
 265-325 1.04 0.85-1.28 0.54 0.28-1.06 
 325-395 0.98 0.86-1.12 0.90 0.59-1.38 
 > 395 1.06 0.95-1.18 1.15 0.85-1.55 
            
Vitamin D (μg/day) < 3.4 1.00  1.00  
 3.4-4.8 1.18 0.97-1.43 0.53 0.28-1.02 
 4.8-6.9 0.97 0.87-1.09 0.96 0.96-1.38 
 > 6.9 0.94 0.86-1.03 1.11 0.88-1.40 
a The relative risk was adjusted for baseline age, body mass index, energy intake,  
 education, marriage, self-reported depression, self-reported anxiety, and  consumption of 
alcohol. 
b The lowest intake quartile as reference. 
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8.4 Additional data on food consumption in those with symptoms of 
depressed mood, anxiety,  and insomnia 
At study entry, 4314 (16%) of men reported depressed mood in the past four months, 6498 
(24%) feelings of anxiety, and 5550 (21%) insomnia. There were no statistical significant 
differences between study subjects, but there was some variation in the intake of energy, 
alcohol, coffee and milk between healthy subjects and subjects with self-reported 
depressed mood, anxiety, and insomnia. 
The mean intake of energy was 1-3% greater and consumption of alcohol 30-33% greater 
in subjects with any such symptoms, compared with symptom-free individuals. Men 
reporting all three symptoms consumed as much as 47% more alcohol than those without 
any symptoms. Subjects with insomnia consumed 7% less coffee than symptom-free 
individuals, whereas those with depressed mood or anxiety consumed only about 2% less 
coffee.
On all four occasions when the symptoms were asked about during the first trial follow-up 
year, 782 men reported depressed mood, 1237 feelings of anxiety, 1234 insomnia, and 166 
men all three symptoms. Their food consumption and nutrient intakes were similar to men 
without these symptoms at baseline (Table 2, in III). Some disparities from the symptom-
free subjects were more obvious, although differences were not statistical significant. The 
mean intake of energy was 7.3% greater in subjects with all three co-existing symptoms 
compared with symptom-free individuals. Subjects with insomnia consumed 10.9% less 
coffee, but 10.2% more milk than those with no symptoms.  
8.5 Additional data on food consumption and intakes of nutrients in 
subjects with bipolar disorder 
There were no statistical significant differences in the consumption of food or intakes of 
nutrients between those with bipolar disorder and healthy individuals (Table 2, in V). 
Logistic regression models gave no significant results. However, there were some 
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variations in intakes of nutrients between bipolar disorder and healthy individuals. In 
addition, the intake of protein was associated with affective status in linear regression 
analysis (t= 2.70, p= 0.01). 
Bipolar twins consumed more meat (31%), fruit and berries (64%), eggs (45%), and milk 
(39%) than healthy co-twins, as calculated in absolute rates between two groups. The mean 
intake of margarine was 34% greater in healthy individuals than in those with bipolar 
disorder. These differences did not remain significant after subjects with a high frequency 
were excluded. The mean consumption of alcohol was 9.9 g/day in the bipolar and 4.1 
g/day in healthy individuals. There were no differences in the consumption of coffee or tea 
on average. 
However, the intake of vitamin B12 was 44% greater in women with bipolar disorder than 
healthy women. In addition, women with bipolar disorder ingested 26% less omega-3 fatty 
acids, and drank less alcohol (p=0.002) than healthy women. Women with bipolar disorder 
also ingested 32% less sugar but 70% more fruits and berries, and gained more energy 
from protein (p=0.005) than healthy women. 
Seasonal association with food items 
In the present study sample, there were three significant associations between dietary 
intakes and the seasonal changes in mood and behaviour. First, the consumption of coffee 
was related to seasonal change in appetite (r=0.55, p=0.04). Second, there was a significant 
correlation between intake of energy and the seasonal change in sleep length (r=0.53, 
p < 0.05). Third, the intake of fruit and berries was linked to the seasonal change in levels 
of energy (r=0.63, p=0.02). 
Finnish Twin Cohort Questionnaire 
There were additional results from the Finnish Twin Cohort Questionnaire from 1981 and 
1990. The mean consumption of alcohol differed significantly between the bipolar and 
healthy twins (6.5 versus 11.2 g/day, p=0.04) in 1981. The mean difference in alcohol 
consumption increase from 1981 to 1990 in twins with bipolar disorder was 2.0 g per day 
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(SD=7.1; 95% CI: -1.9 to 5.9) and in healthy twins 0.0 g per day (SD =7.0; 95% CI: -5.5 to 
5.4). Twins with bipolar disorder drank on average 2.0 g more alcohol in 1990 and 0.3 g 
more alcohol in 2002, whereas healthy co-twins drank 5.0 g per day less alcohol in 2002 as 
compared with their daily consumption in 1981. 
There was no significant difference in smoking between the bipolar and healthy twins. In 
1990, the mean years smoked was 18.8 years in twins with bipolar disorder and 26.1 years 
in healthy co-twins.  The mean difference in smoking from 1981 to 1990 in the twins with 
bipolar disorder was 6.8 years (SD= 4.0; 95% CI: 3.5 to 10.2) and in healthy twins 10.8 
years (SD=2.3; 95% CI: 5.0 to 16.6). 
There were no significant differences in the consumption of coffee or tea between the 
bipolar and healthy twins in the Finnish Twin Cohort Questionnaire data. Bipolar twins 
consumed 5.6 cups of coffee (SD=3.3; 95% CI: 3.9 to 7.2) and 2.2 cups of tea per day 
(SD=1.9; 95% CI: 1.0 to 3.3), whereas healthy twins consumed 5.1 cups of coffee 
(SD=2.7; 95% CI: 3.5 to 6.7) and 2.3 cups of tea per day (SD=2.9; 95% CI: 0.2 to 4.7). 
8.6 Seasonal changes in subjects with bipolar disorder  
At group level, there were significant differences in the extent of seasonal changes in mood 
(p=0.02), weight (p=0.02), appetite (p=0.04), and levels of energy (p=0.02), as well as in 
the GSS (p=0.004) between the bipolar and healthy twins. The changes were greater in the 
bipolar twins. 
Twins with bipolar disorder had most (31%) of their hospital admissions during autumn, 
but there were no statistically significant differences  between the season (Table 2, in IV). 
The distribution of depressive and manic episodes did not differ significantly by season 
(p=0.06), although the depressive episodes were tended most common in autumn and 
winter, and manic episodes in autumn and summer. Also taken into account was the most 
frequent season of admission for each individual with recurrent episodes (n=33). Most of 
the admissions (52%) occurred in autumn, admission due to depressive episodes being 
most frequent during autumn and winter (82%). Seasonal distribution of hospital 
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admissions was compared with self-reports of feeling the worst, (p=0.13). Similarly, the 
self-reported length of sleep was analysed. The period of sleeping most (longest length of 
sleep) did coincide with the admissions, but this association did not reach statistical 
significance. The period of sleeping least (shortest length of sleep) was not associated with 
admissions (p=0.48). 
There was a significant difference in the effect of dry days on feelings of wellbeing 
(p=0.04) between the bipolar and healthy twins. Dry days induced a more positive effect 
on wellbeing in the bipolar twins. Interestingly, short days had only a negative effect on 
wellbeing in the monozygotic twins, whereas the response was diverse among the 
dizygotic twins (p=0.02).  
Within twin pairs there were greater seasonal changes in sleep length (p=0.01), and mood 
(p=0.01), and the GSS (p=0.03) was higher in the bipolar twins compared with their 
healthy co-twins. In addition, sunny days (p=0.03) had a greater positive effect on 
wellbeing in the bipolar than healthy co-twins. The mean difference (95% CI) between the 
bipolar and healthy twins in the GSS was 3.40 (0.65 to 6.15), in sleep length 1.00 (0.36 to 
1.64), in social activity 0.80 (0.01 to1.59), in mood 0.93 (0.29 to 1.58), and in sunny days 
1.00 (0.15 to 1.85). 
The intrapair correlation of the GSS was 0.16 for seven monozygotic twin pairs, and 0.21 
for 20 dizygotic twins. The intrapair correlation of the GWS was -0.16 for the monozygotic 
twins, and 0.04 for the dizygotic twins.
8.7 Sleep length and debt in subjects with bipolar disorder 
The bipolar twins slept longer nights, as self-reported with the FTCQ in 1990, compared 
with healthy twins (p=0.01, Table 3, in IV). At follow-up in 1999, as assessed in the 
interview, the mean sleep length was 8.21 hours in the morning types (morning larks) and 
7.66 hours in the evening types (night owls), as calculated from the SPAQ. When data on 
sleep length derived from the SPAQ were compared with those from the FTCQ, healthy 
morning and evening types slept less in 1999 than 1981 (Table 4, in IV). The morning 
62 
types with bipolar disorder slept more in 1999 than 1981. The evening types with bipolar 
disorder slept the same time or less than before. When groups of morning types and 
evening types were analysed the longest length of sleep was 8.59 hours among the morning 
types (in winter), and the shortest was 6.70 hours among the evening types (in summer).  
8.8 Circadian type in subjects with bipolar disorder 
Among the twin cohort studied the stability of circadian preference remained good from 
1981 to 1986 (p < 0.0001). The morning type tended to become slightly more prevalent 
with age in the whole cohort, as well as in this study sample (Figure 1, in IV). There were 
no significant differences in the MES, or in the circadian type preferences between the 
bipolar and healthy twins (Table 3, in IV). Whether the MES or GSS differed between 
monozygotic and dizygotic twins, or between men and women, was also checked. There 
were no differences.  
The eveningness preference was associated with a higher GSS (partial correlation, r = -
0.045, p < 0.01) after controlling for sex, age, zygosity, and affection status. This 
association was seen only for the total score, and there were no significant associations 
between the circadian type and seasonal changes in length of sleep, weight or appetite. In 
the present study, weight and appetite usually increased in winter and decreased in 
summer, but there were no statistical significant differences. In 51% of the individuals the 
most common change in weight was 2-3.5 kg during the year, and the 32% of individuals’ 
food preferences changed by season.
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9 DISCUSSION
9.1  Strengths and limitations of the study 
9.1.1  Study subjects 
The ATBC Cancer Prevention Study (I, II, II) was an exceptionally large population-based 
study sample. There were 29 133 men followed-up for six to eight years. The limitations of 
studies I, II, and III are that the participants were men only, of a restricted age cohort, and 
all were smokers at study entry. Strict exclusion criteria limit the generalizability of these 
study findings to the general population, but the study still provides valid and reliable data 
on a community-based, very homogenous sample of older men. 
In the twin studies (IV, V) the sample size was small, but derived from an extensive 
population-based sample using the National Population Register and the Finnish Twin 
Cohort. The participation rate (88%, 67 out of 76 in total) was high. However, there were 
only 39 study subjects left in the final study analyses (67% of those invited). This 
participation rate could limit the generalizability of these findings. The reason for the low 
participation rate is most probably related to the personal tedium of long-lasting studies 
and to the general problems of participation. Using the Finnish twin cohort the estimated 
incidence of bipolar disorder I in the population during the follow up period of 1970 to 
1991, the annual incidence in the 1954-1959 birth cohort was 5.8 to 100 000 (95% CI: 5.4 
to 6.3; Kieseppä et al. 2004). The Health 2000 project reports a lifetime prevalence of 
bipolar I disorder of 0.24% in Finland (Perälä et al. 2007). The small number of study 
subjects limits the generalizability of the findings, but this study still provides valid and 
reliable data on bipolar twins. Because of the small study sample in Study IV differences in 
the dietary intake between bipolar disorder subjects and healthy subjects may not appear. 
Also, this was a study of twins, which as such can limit the generalizability of these results 
to the general population. The study sample was collected from Finland, a far northern 
country, which can limit the generalizablity of the findings on seasonal changes (Studies 
IV, V) for countries at less extreme latitudes.  
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9.1.2 Study design 
The ATBC Cancer prevention study was a prospective study with a follow-up period of 6 
to 8 years. Studies I and II applied a prospective study design. Study III was a partly cross-
section study, which cannot prove causal connection between diet and symptoms of 
depression, anxiety, or insomnia. 
Studies IV and V were cross-section studies, which again limits the findings, because 
causal connection between bipolar disorder and dietary intake of nutrients cannot be 
proved.  However, there were data available on sleeping habits, alcohol and tobacco 
consumption for reference from the Finnish Twin Cohort Questionnaires from 1981 and 
1990. 
9.1.3 Psychiatric diagnoses  
In the ATBC Cancer Prevention Study the data on hospital admissions were derived from 
the National Hospital Discharge Register, which covers in-patient admissions to all 
medical and psychiatric hospital beds in Finland. The accuracy of the register compared 
with medical records is excellent, with data being identical in about 95% of the primary 
diagnoses (Keskimäki and Aro, 1991). Versatile data on depression, which increases the 
validity and reliability of the assessment, were collected. 
In the twin studies (IV, V) all the probands and co-twins were interviewed to confirm the 
diagnosis of the probands and to assess any mental disorders of the co-twins by one of the 
investigators (T.K) using the Structured Clinical Interview for DSM-IV (SCID) (Spitzer et 
al. 1997).  
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9.1.4 Questionnaires 
Food Use Questionnaire and Food Frequency Questionnaire 
Dietary intake and alcohol consumption were assessed with a self-report but validated food 
use questionnaire to measure the habitual dietary intake over the previous year as 
completely as possible. Both the food use and food frequency questionnaire have been 
validated against food records data (Pietinen et al 1988; Paalanen et al. 2006). In the food 
use and frequency questionnaires the information relies on the subject’s memory, and 
because of the defined food list, some information about the foods actually eaten may be 
missed. Paalanen et al (2006) reported overestimation with the FFQ compared to food 
records. The most overestimated nutrients were polyunsaturated fatty acids, long chain n-3 
fatty acids, carotenoids, vitamin E, and vitamin C in both women and men. However, since 
there is underreporting in food records, overestimation in the FFQ could be expected. Also, 
the correlations for nutrients between the FFQ and food records were higher in women 
than in men, but in the same range as earlier studies. 
In the validation process of FFQ the food records data were not optimal, because the food 
record covered only three days. This may be a limitation of the validation study (Paalanen 
et al. 2006). Also, Pietinen et al (1988) reported that there was overestimation for potatoes, 
fruits and juices, while the consumption of fats, fish and coffee, alcohol, and sugar was 
slightly underreported. 
In the ATBC Cancer Prevention Study the reproducibility of this method is 0.6-0.7 and the 
validity 0.6-0.7 for most nutrients (Pietinen et al. 1988). In the twin studies the Pearson 
correlation coefficients ranged from 0.14 for retinol to 0.70 for alcohol. The correlation 
coefficient for long-chain omega-3 fatty acids was 0.35 in men and 0.20 in women 
(Paalanen et al. 2006). These studies concluded that the self-administered food use 
questionnaires are useful for measuring individual or group intakes for a variety of 
nutrients. In the present study, only two healthy men filled in the FFQ in Study IV.  
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The eating habits of twins are rather similar, even in adulthood. The temporal pattern, 
energy intake, meal frequency, portion size, meal macronutrient intake, alcohol 
consumption, and water composition have strong heritabilities, whereas the shared familial 
environment has no major impact on the levels or patterns of eating in adulthood (de 
Castro, 1993). As study IV was a study of twins, this may limit the generalizability of these 
results. 
Symptoms of depressed mood, anxiety and insomnia 
Assessment of self-reported depression based only on a single item compromises the 
specificity. It has been reported that two to three questions only may be as effective as a 
more detailed screening instrument in detecting probable cases of major depression 
(Whooley et al. 1997; Arroll et al. 2005). One of these questions (“During the past month, 
have you often been bothered by feeling down, depressed, or hopeless?”) is rather similar 
to the item that it was used for being indicative of depressed mood. 
SPAQ
Magnusson et al (1997) found that six items of GSS correlated well in a population based 
study in Iceland and the scale had a high internal consistency. They concluded that GSS is 
well constructed and reliable in measuring seasonal changes. Young and co-workes (2003) 
also reported good internal consistency and two-month test-retest reliability. Magnusson 
(1996) also found excellent sensitivity and specificity (94% and 73%, respectively) for a 
“winter problem” group, which included subjects with seasonal affective disorder and 
subsyndromal seasonal affective disorder. 
Both the seasonal variation in mood and behaviour and the changes in wellbeing attributed 
to local weather conditions were retrospectively assessed using a self-rating scale. Score on 
the SPAQ tend to vary by season, but not by day length (Lund and Hansen, 2001). 
However, this is not a true limitation in this study, because the SPAQ was administered via 
research interviews that were distributed evenly over the year. The linguistic accuracy of 
the Finnish version has been checked with back translation, but the psychometric 
properties are not published yet (personal communication, Timo Partonen). 
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MEQ
The MEQ has been validated by studying oral temperatures, typical bed and arising times, 
and sleep length of study subjects (Horne and Östberg, 1976). They reported that morning 
types had a significantly earlier peak time than evening types and tended to have a higher 
daytime temperature and lower post peak temperature. Morning types retired and arose 
significantly earlier than evening types. There was correlation between the peak time and 
MEQ (-0.51, p < 0.01). The linguistic accuracy has been checked with back translation, but 
the psychometric properties are not published yet (personal communication, Timo 
Partonen).
9.2 Associations between mood disorders and mood symptoms and 
dietary intakes of specific nutrients 
9.2.1 Amino acids 
The intakes of two amino acids, serine and lysine, were associated with the increased risk 
of hospital treatment due to MDD. Also, the intake of energy from protein was greater in 
subjects with bipolar disorder than healthy subjects. It has been reported that a high intake 
of protein seems to increase alertness (Rogers, 2001).  Maybe patients prefer to eat foods 
with a high concentration of proteins because such meal may easily produce higher levels 
of activity. 
Alternatively, the positive associations between serine and lysine intakes levels and the risk 
of MDD may have simple occurred by chance only due to multiple comparisons. There is 
evidence of differences in the plasma concentrations of serine in depressed subjects 
compared with healthy subjects (Fekkes et al. 1994; Maes et al. 1998, Sumiyoshi et al. 
2004). These findings suggest that serine may participate in the regulation of mood. The 
role of lysine in brain function is still relatively unknown and evidently worth further 
study.
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In the present study, there were no associations between intake of tryptophan and mood 
symptoms and disorders. Tryptophan is a precursorof serotonin, which is known to play a 
key role in many brain functions, such as mood regulation. A number of studies have 
shown that acute tryptophan depletion produces depressive symptoms and results in 
worsening of mood, mainly in subjects with depression or vulnerability to depression 
(Neumeister et al. 1998; Spillmann et al. 2001). For this reason, tryptophan 
supplementation has been applied for the treatment of depressed patients (Lam et al. 1997). 
However, a number of negative studies have been published recently, suggesting that the 
effects of tryptophan depletion on mood are less consistent (Bell et al. 2001; Van der Does, 
2001), and the rationale for augmentation has now been challenged (Nelson, 2000). The 
present study results agree with these recent findings in that the effect of tryptophan on 
mood may be less robust than earlier assumed. Furthermore, there are no data showing 
whether serum serine or lysine concentrations can affect the brain tryptophan uptake by the 
brain. There are no data on the effects of smoking on amino acid metabolism.  
9.2.2 Omega-3 fatty acids and fish 
Neither dietary intake of omega-3 fatty acids, nor fish consumption showed any association 
with low mood and related outcomes. In the present study both the dietary intake of omega-
3 fatty acids, and fish consumption , were linked to the three-level assessment of low mood: 
as a symptom (self-report) and as pathology (disorder or suicide) in a population. This 
finding conflicts with the some results of Finnish population based studies. Tanskanen et al. 
(2001a; 2001b) and Timonen et al. (2004) have reported that those who rarely eat fish have 
higher risk of depression, but this association was found only in women in two studies. 
Unfortunately, there were no women in the present study, but the study population was 
substantially bigger than other population based studies. Another strength of the present 
study was the MDD diagnoses from National Hospital Discharge Register. In other 
population based studies depressive diagnoses have been diagnosed by questionnaires. 
Even in same country (Finland) there are no consistent results for both sexes about the 
associations between fish consumption and mood disorders. 
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Moreover, there are conflicting findings from supplemental use of omega-3 fatty acids in 
mood disorders. Three placebo-controlled trial have found therapeutic effects of omega-3 
fatty acids in depression (Nemets et al. 2002; Peet et al. 2002; Su et al. 2003), but other 
studies did not find beneficial effects (Marangell et al. 2003; Silvers et al. 2005). The 
primary study of Stoll et al. (1999) reported that supplemental use of omega-3 fatty acids 
may have therapeutic effects on patients with bipolar disorder. However, the latest study 
failed to confirm these findings (Keck et al. 2006). 
The doses have been 1 g to 9.6 g per day in studies with supplemental use of omega-3 fatty 
acids. Usually the doses used in these studies have exceeded by several times the dietary 
intake levels (average intake of 2.2 g/day vs 0.47 g/day from fish). The average intake of 
omega-3 fatty acids tends to be rather similar across most Western countries. For example, 
the average intake of omega-3 fatty acids was 1.2 g/day in men in the USA (Suzuki et al. 
2002). So the overall amount of omega-3 fatty acids in the diet of the present study 
population (2.2 g/day) is higher but still in line with that in other industrialized populations.  
This study subjects reporting anxiety had higher intakes of omega-3 and omega-6 fatty 
acids. The one exception was that omega-3 fatty acids from fish were not linked to any of 
the symptoms. Margarine was revealed as the main source of omega-3 fatty acids from 
vegetables, and of omega-6 fatty acids. Subjects with depressed mood also had a higher 
intake of omega-6 fatty acids. Because 3,138 (73%) subjects with depressed mood also had 
feelings of anxiety, it may be that anxiety is the dominant symptom, and the greater intake 
of omega-3 and omega-6 fatty acids is primarily related to feelings of anxiety. There are no 
previous studies about associations between omega-6 fatty acids and mood. It has been 
reported that smokers have lower erythrocyte polyunsaturated fatty acids status (Hibbeln et 
al. 2003). In the present study there were no data on erythrocyte polyunsaturated fatty acids 
levels. 
9.2.3 Vitamins 
The main finding in the vitamin study was that there was no association between the intake 
of vitamins (folate, B12, B6, B2, B1, vitamin D), or of homocysteine, and the risk of 
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subsequent hospital treatment for affective disorder. The intakes of these vitamins 
exceeded the daily recommendations. It has been hypothesized that a combination of 
decreased appetite, decreased absorption, and increased utilization of folate results in folate 
depletion and eventually produces a central nervous system effect (Abou-Saleh and 
Coppen, 1986). The present study showed that there were no low intakes of folate or B12
vitamin.
In the bipolar twin study, too, the dietary intakes of vitamins exceeded the daily 
recommendations and showed no association with bipolar disorder, except for vitamin B12.
In this study sample, the intake of vitamin B12 was greater in twins with bipolar disorder 
than in healthy co-twins. The best sources of vitamin B12 are meat, liver, milk, and fish. 
There is no obvious explanation why the intake of vitamin B12 was greater in twins with 
bipolar disorder. The hypotheses which support an association of vitamin B12 and mood 
disorders need more study. Shortage of vitamin B12 has been linked to various neurological 
and psychiatric disorders, such as affective illness (Goggans, 1984; Hector and Burton, 
1988; Lindenbaum et al. 1988; Healton et al. 1991). It has been reported that depressed 
subjects have low serum vitamin B12 levels (Pennincx et al. 2000; Tiemeier et al. 2002), 
but there are also contradictory findings (Fava et al.1997; de Jong et al. 2001; Bjelland et 
al. 2003).  
Another explanation for the association of vitamin B12 with depression is the effect that 
vitamin B12 may have on the circadian system. Vitamin B12 seems to modulate melatonin 
secretion (Yamazaki et al. 1991), to increase core body temperature later in the day 
(Uchiyama et al. 1995), and to enhance response to light exposure (Hashimoto et al. 1996). 
Smoking is known to be associated with an increased plasma homocysteine level and 
reduced levels of folate, vitamin B12 and vitamin B6 (de Bree et al. 2001a; 2001b; 
O’Callaghan et al. 2002). In this study there were no data on serum levels of vitamins. 
However, smokers in this study clearly exceeded daily recommendations for the intakes of 
folate, vitamin B12 and vitamin B6 clearly. 
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9.3 Dietary intakes of food consumption and nutrients in those with 
symptoms of depressed mood, anxiety, and insomnia 
Subjects with any or all of the symptoms consumed more alcohol than the symptom-free 
subjects. Subjects with depressed mood, anxiety and insomnia consumed the most alcohol 
of all, and they received 6% of their total energy from alcohol, compared to 4.3% in 
subjects with no symptoms. Energy from alcohol did not, however, explain the differences 
in mean intake of energy between groups. Alcohol, in particular, is a notable source of 
extra energy, whose excessive consumption should be avoided when suffering mental 
health problems. Body-mass index was lower, despite a higher caloric intake, in subjects 
with symptoms compared to symptom-free subjects. It also found that subjects reporting 
depressed mood consumed more carbohydrates than subjects with no symptoms in the 
present study. This finding is consistent with the previous reports that some depressed 
subjects try to alleviate depressive symptoms by carbohydrate craving (Christensen and 
Pettijohn, 2001). Depressed subjects tend to consume more carbohydrates in their diets 
than non-depressed individuals (Christensen and Somers, 1996). 
9.4 Dietary intake, drinking and smoking and bipolar disorder 
There were no significant differences in the consumption of foods or the intakes of 
nutrients between twins with bipolar disorder and healthy co-twins. Logistic regression 
models gave no significant results. However, there were some variations in the dietary 
intakes of nutrients. The main findings of the this study are that the intake of energy from 
protein and the intake of vitamin B12 are greater in twins affected with bipolar disorder 
than in healthy co-twins. Bipolar twins also ingesteded more meat, fruits and berries, eggs, 
and milk, and drank more alcohol than healthy twins. Interestingly, women with bipolar 
disorder had a more healthy way of eating and drinking than healthy women. It was 
hypothesised in this study that women with bipolar disorder have less symptoms of bipolar 
disorder and less hospital admissions than men with bipolar disorder. However, there were 
no differences in the number of admissions between men and women with bipolar disorder. 
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9.5 Sleep habits and seasonal changes in subjects with bipolar disorder 
It is known that sleep disturbances have an impact on the mood, and the present study 
aimed to include the investigation of sleep habits and circadian rhythms in subjects with 
bipolar disorder. The circadian system is responsible for regulating many physiological and 
behavioural rhythms in 24-hour cycles (Reppert and Weaver, 2002). Deletions of the 
circadian genes results not only in circadian abnormalities, but also in metabolic 
abnormalities of glucose and lipid homeostasis, a phenotype resembling the metabolic 
syndrome. Turek et al (2005) reported that rats with a mutation in the circadian clock gene 
had disturbances in the diurnal feeding rhythm which resulted in them becoming obese and 
developing metabolic syndrome. Rudic et al. (2004) have demonstrated that mutations in 
the clock gene affected to plasma glucose and triglyceride concentrations and influence the 
development of glucose intolerance and insulin resistance in response to a high-fat diet. 
Research is urgently needed to clarify these connections in detail.
9.5.1 Sleep habits 
During 1981 to 1999 follow-up, the length of sleep shortened among the healthy twins. 
Shortage of sleep has been a common phenomenon in western societies. In contrast, the 
bipolar twins of sample slept even more in 1999. When subjects with a greater sleep debt 
and subjects with no sleep debt were compared, there was no difference in the intake of 
energy.  It has been observed that those who sleep less than seven hours per night are more 
likely to be obese (Gangwisch et al. 2005; Patel et al. 2006). It has also been reported that 
that subjects with sleep debt have more obesity, and that sleep debt is a risk factor for 
metabolic syndrome (Wolk and Somers, 2007). The verification of this association needs 
further research.   
9.5.2 Circadian type 
There were no differences in circadian type between patients with bipolar disorder and 
healthy study subjects. Preference for evening activities has been associated with a greater 
need for sleep (Taillard et al. 1999). In this study, the evening types had greater sleep debt 
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than the morning types. This finding agrees with previous data showing that the evening 
types do experience a need for longer sleep (Taillard et al. 1999). 
9.5.3 Seasonal changes
 It was found that seasonal changes in sleep length and in mood were greater in twins with 
bipolar disorder compared with their co-twins with no mental disorder. This accords with 
previous finding of a circadian fluctuation in bipolar disorder (Shin et al. 2005).   
There was a positive correlation between the intake of energy and the seasonal change in 
sleep length. Twins with bipolar disorder ingested more energy than healthy twins. 
Disturbances in circadian rhythms probably induce fatigue. It is possible that those who 
feel tired tend to eat more, for instance fruits and berries, and to drink more coffee in order 
to reduce sleepiness and stay alert.
It was found that autumn was generally the worst time for patients with depressive and 
manic episodes, especially those with recurrent episodes. This may also affect dietary 
intake.
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9.6  Implications for future research 
1. In this study there were no associations found between nutrition and mood disorders in 
men, although these results need to be confirmed with population based-studies which also 
include women. In particular, the possible beneficial effects of omega-3 fatty acids on 
mood need further research.
2. In this study the intake of nutrients exceeded the daily recommendations and there were 
no associations between in the dietary intakes of nutrients and mood disorders and 
symptoms. It remains to be elucidated whether there is a difference in the metabolism of 
nutrients between subjects with mood disorders and healthy controls. Such studies would 
require total serum levels of different nutrients in depressed people and healthy study 
subjects. It is important to find out whether there are individual differences in metabolism 
or bioavalability, because if so it may be possible to maybe prevent depression by 
increasing the daily intake of specific nutrients. 
3. This present study did not clarify the value of supplemental use of omega-3fatty acids. 
However, the findings of earlier studies indicate that more research is needed to clarify the 
beneficial effects of supplemental use ofomega-3 fatty acids on mood disorder. 
4. More studies of the circadian clock genes and their associations with mood disorders are 
needed. It is important to investigate how these genes affect the diurnal rhythms of feeding 
and sleeping and whether polymorphisms of these genes can to some extent explain the 
pathogenesis of bipolar disorder. This may pave the way to new options in the prevention 
and treatment of bipolar disorder. It will also be important to study how diet and lifestyle 
habits (exercise, sleep) affect regulation of these genes and whether mood disorders can be 
prevented by specific interventions of life habits, especially in those with high risk of mood 
disorders.
5. The present study found that autumn was the worst time for bipolar patients, as most of 
hospital admissions were in autumn. This should be taken into account in future studies, 
especially in the assessment of the dietary intake. It should also be noted in clinical work.  
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10 CONCLUSIONS 
The present study focused on five specific questions as follows. 
Is the intake of tryptophan related to depression? (Study I) 
Finding: Tryptophan did not associate with self-reported depression, hospital admission 
due to MDD, or suicide. 
Is the intake of omega-3 fatty acids related to depression? (Study II) 
Finding: Omega-3 fatty acids did not associate with self-reported depression, hospital 
admission due to MDD, or suicide.  
How does mood affect eating habits? (Study III) 
Finding: There were no statistically significant differences between healthy subjects and 
subjects with depressed mood, anxiety symptoms, or insomnia. However, men reporting all 
three symptoms consumed as much as 47% more alcohol than those without any 
symptoms.
How does bipolar disorder affect eating habits? (Study IV) 
Finding: After adjustment for sex and age, the intakes of vitamin B12 and of protein were 
significantly associated with bipolar disorder.  
How does bipolar disorder affect seasonal changes in mood and behaviour? (Study V) 
Finding: It was found that seasonal changes in sleep length and in mood were greater in 
twins with bipolar disorder compared with their co-twins with no psychiatric disorder. 
In conclusion, no significant association between dietary intakes of nutrients and mood 
disorders in the present study. These results did not lend support to the view that dietary 
intakes have a major role in mental health. More studies are needed to clarify these 
connections in future. 
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